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Abstract
Self-Monitoring of Blood Glucose (SMBG) for Type-2 Diabetes (T2D) remains highly
challenging for both patients and doctors due to the complexities of diabetic lifestyle data
logging and insufficient short-term and personalized recommendations/advice. The recent
mobile diabetes management systems have been proved clinically effective to facilitate self-
management. However, most such systems have poor usability and are limited in data analytic
functionalities. These two challenges are connected and affected by each other. The ease of
data recording brings better data for applicable data analytic algorithms. On the other hand,
the irrelevant or inaccurate data input will certainly commit errors and noises. The output of
data analysis, as potentially valuable patterns or knowledge, could be the incentives for users
to contribute more data.
We believe that the incorporation of machine learning technologies in mobile diabetes man-
agement could tackle these challenge simultaneously. In this thesis, we propose, build, and
evaluate an intelligent mobile diabetes management system, called GlucoGuide for T2D pa-
tients. GlucoGuide conveniently aggregates varieties of lifestyle data collected via mobile
devices, analyzes the data with machine learning models, and outputs recommendations.
The most complicated part of SMBG is diet management. GlucoGuide aims to address
this crucial issue using classification models and camera-based automatic data logging. The
proposed model classifies each food item into three recommendation classes using its nutrient
and textual features. Empirical studies show that the food classification task is effective.
A lifestyle-data-driven recommendations framework in GlucoGuide can output short-term
and personalized recommendations of lifestyle changes to help patients stabilize their blood
glucose level. To evaluate performance and clinical effectiveness of this framework, we con-
duct a three-month clinical trial on human subjects, in collaboration with Dr. Petrella (MD).
Due to the high cost and complexity of trials on humans, a small but representative subject
group is involved. Two standard laboratory blood tests for diabetes are used before and af-
ter the trial. The results are quite remarkable. Generally speaking, GlucoGuide amounted to
turning an early diabetic patient to be pre-diabetic, and pre-diabetic to non-diabetic, in only 3-
months, depending on their before-trial diabetic conditions. cThis clinical dataset has also been
expanded and enhanced to generate scientifically controlled artificial datasets. Such datasets
can be used for varieties of machine learning empirical studies, as our on-going and future
research works.
GlucoGuide now is a university spin-off, allowing us to collect a large scale of practical
diabetic lifestyle data and make potential impact on diabetes treatment and management.
Keywords: machine learning, lifestyle data, T2D management, mobile computing
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Chapter 1
Introduction
Diabetes is a metabolic disease in which patients have abnormally high blood glucose. There
are two main types of diabetes: Type-1 and Type-2 Diabetes. Type-1 Diabetes (T1D) is a
disease in which the pancreas produces little or no insulin. As such, glucose builds up in blood
instead of being used for energy. Individuals with T1D need to inject insulin as prescribed.
Type-2 Diabetes (T2D), on the other hand, is a disease in which the pancreas does not produce
enough insulin, and/or the human body does not properly use the insulin it makes [2, 3]. There
is also a type of diabetes called Prediabetes, which refers to blood glucose levels that are higher
than normal, but not yet high enough to be diagnosed as T2D [2].
Diabetes, if not well-treated, will develop many long-term complications including heart at-
tack, stroke, amputations, and blindness. According to WHO 2013, 347 million people world-
wide have diabetes, and T2D patients comprise more than 90% of them. Thus, improving the
treatments of T2D is significant to patients’ condition and our society [2].
After a person is diagnosed with T2D, usually medications will be prescribed by doctors.
Also, a protocol called Self-Monitoring of Blood Glucose (SMBG) will be advised by health-
care providers to help the patient achieve proper blood glucose targets [2]. In fact, blood
glucose is affected by a large number of lifestyle and clinical factors, including what you ate,
how long ago you ate, your previously blood glucose levels, physical activity, mental stress, ill-
ness, sleep patterns, and so on [2]. Each factor can have different impact on a specific person’s
blood glucose and there could also be complex interactions among these factors.
1.1 Challenges and Barriers of Diabetes Management
Adopting and maintaining healthy lifestyle changes is highly challenging for T2D patients [4].
For example, the overwhelming complexity of carbohydrate or calories counting presents an
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often insurmountable obstacle for most T2D patients. Also, when the patient’s blood glucose
is high, it can be difficult to determine which factor(s) causes it. On the other hand, the time-
constraints for healthcare providers do not allow for 24/7 real-time monitoring and personalized
advice, leaving a patient in a potentially life-threatening situation.
The rapid development of mobile computing starts a new era of diabetes management.
Mobile apps and wearable medical devices have significantly facilitated diabetes management
regarding their usabilities. For example, it is possible now that patients can conveniently sync
their blood glucose readings from Bluetooth-enabled glucometers to their mobile apps and send
them to health providers via the Internet. Their health providers can log-in Web portal to review
and analyze their blood glucose readings. Such ubiquitous procedure is a revolution. However,
there are still two main challenges preventing the current mobile diabetes management systems
from reaching their full potential.
The first challenge is related to the system input, i.e., the complexities of lifestyle data
logging. Even utilizing the modern mobile diabetes system and wearable sensors, data logging
is still troublesome and time-consuming, especially for diet and glucose levels. For example,
most systems use food database searching to help patients record diet information. However,
to record every detail of a meal, patients need to search each food item in the meal and estimate
its serving and portion size, which makes diet recording a very time-consuming process. As
for blood glucose levels, continuous blood glucose monitoring (CGM) devices or finger-prick
based glucometers are mostly used to estimate glucose concentration from real blood samples,
which means testing blood glucose level is painful and costly [20, 59].
The second challenge is related to the system output. More specifically, most systems are
lacking evidence-based, personalized, and instantaneous feedback to patients’ diabetes man-
agement practices. Diabetic lifestyle data now are collected without being adequately ana-
lyzed. Some popular systems such as Glooko TM and Glucose Buddy TM, only log and plot
blood glucose and other lifestyle data, without data analytics on patient data to actively advise
and engage patients. A few others, such as WellDoc [5], do give patients personalized advice
but only prescribed by doctors who need to access the system to review their patients data.
That is in fact not practical when the data volume is huge and data structure becomes complex.
1.2 Our Solutions
A trend in healthcare analytics is taking advantage of machine learning models to discover
patterns from the large scale of clinical data and to aggregate medical domain knowledge from
a variety of sources. Specifically, predictive modeling, as an important component of machine
learning, is a process used in predictive analytics to create one or multiple models with fore-
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casting probabilities and trends. It could be utilized to facilitate the processing of patients’
data and allow patients and their health providers to interact in a more convenient and timely
manner.
To tackle the data input issue. We believe that machine learning technologies can be utilized
to facilitate lifestyle data input. For example, it is possible now that patients can take pictures
of a food item, and that food item can be recognized using predictive models such as deep
neutral networks. Then, we can use the food meta-data learned from machine learning models
to obtain detailed nutrition information from querying food databases.
Machine learning could also be used to enhance the outputs of diabetes management sys-
tem, i.e., learning of lifestyle data and output practical hidden patterns or knowledge. Numer-
ous research works have been proposed to use predictive models in diabetes diagnosis and risk
analysis [6, 7, 8, 9, 10, 11, 12, 13, 14, 15]. They aim to predict diabetes clinical diagnosis and
risk factors based on patients’ profile data. Another challenging research area is blood glucose
prediction. With the help of reliable blood glucose prediction models, patients would be able
to take actions proactively to stabilize their predicted blood glucose levels. Previous studies
have been focusing on the exclusive CGM (Continuous Blood Glucose Monitoring) data, and
achieve remarkable prediction accuracy [16, 17, 18, 19]. To elaborate, CGM is an advanced
way to measure glucose levels in real-time (or short sampling interval like 5 minutes) through-
out the day and night. In particular, glucose sensors are inserted under the skin to measure
glucose levels in tissue fluid. They are also connected to a transmitter that sends the informa-
tion via wireless networks. Such procedure mostly used in clinical treatments for T1D patients,
which are usually costly and publicly inaccessible.
As for T2D patients, we believe that the design principle of blood glucose prediction frame-
work should focus on the lifestyle data and discrete finger-prick blood glucose samples since
they are the essences of T2D self-management. Furthermore, the lifestyle data nowadays can
be collected cost-efficiently (comparing to the clinical data such as CGM data) using modern
mobile devices. The lower of the cost of lifestyle data collection makes it has the potential of
being expanded to big informative data.
In this thesis work, we propose, build, and evaluate an intelligent mobile diabetes man-
agement system, called GlucoGuide for T2D patients. GlucoGuide conveniently aggregates
varieties of lifestyle data collected via mobile devices/sensors, analyzes the data with predic-
tive models, and outputs the model outcomes as recommendations.
The most complicated part of self-management is diet management, and GlucoGuide aims
to address this crucial issue using classification models and mobile-camera-based automatic
data logging. The proposed classification model can categorize any food item into three rec-
ommendation classes using its nutrient and textual features. Our evaluation shows that the best
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model classification accuracy is around 95%, indicating this method is empirically effective
and reliable for food items recommendations.
A lifestyle-data-driven recommendations framework in GlucoGuide can output short-term
and personalized recommendations for lifestyle changes to help patients stabilize their blood
glucose level. This framework conduct predictive modeling on patients’ lifestyle data to predict
blood glucose levels. Each prediction iteration can also rank lifestyle factors in terms of their
importance or relevance. The data-driven recommendations regarding the important factor(s)
will be sent to patients.
To collect training data from real patients and evaluate the clinical effectiveness of this
framework, we have collaborated with Dr. Petrella’s health team to conduct a three-month
clinical trial on human subjects. Due to the high cost and complexity of trials on human, a
small but representative subject group is involved. Using the lifestyle data collected from this
group, the performance of our blood glucose prediction framework is similar to state-of-the-art
methods [20, 16] using clinical CGM data.
In terms of clinical effectiveness, two standard laboratory blood tests for diabetes are used
before and after the trial. The results are quite remarkable. Generally speaking, GlucoGuide
amounted to turning an early diabetic patient to be pre-diabetic, and pre-diabetic to non-
diabetic, in only 3-months, depending on their diabetic conditions before the trial.
Since the collected clinical dataset is relatively “small“ regarding its volume and dimen-
sions, our blood glucose prediction framework was possibly not converged. Meanwhile, we do
not have large scale of practical diabetic lifestyle datasets to explore the potential of our model
at this point. As such, we have designed an effective mechanism to expand and enhance this
clinical trial dataset. After the data expansion, we have obtained large scientifically controlled
artificial datasets for further studies on blood glucose predictions.
Specifically, we first use parametric statistical inference to find the properties of underlying
distributions and potential dependencies. We have also applied diabetic domain knowledge to
make certain assumptions on the data and determine all the well-known feature dependencies
and parameters. The unlabeled lifestyle datasets will be sent to AIDA (a very popular online
diabetes simulator) to generate blood glucose labels [75, 76]. Our evaluation results show that
this generation process is effective. Such artificial datasets can also be used for varieties of
machine learning empirical studies such as blood glucose warnings, missing value imputation,
data sparsity analysis, transfer learning, etc., as our on-going and future research works.
GlucoGuide now is a university spin-off, allowing us to collect a large scale of practical
diabetic lifestyle data and make potential impact on diabetes treatment and management. As
far as we know, diabetic datasets similar to ours are not publicly available at this point, thus, we
also plan to release our de-identified datasets for better collaborations with peer researchers.
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The remaining chapters of the thesis are presented as follows: We first review the prior rele-
vant research and developments on mobile diabetes management system and diabetes modeling
using predictive models in Chapter 2. Then, our research question is defined in Chapter 3, as
well as the design principle of GlucoGuide system. The diet management sub-system and
food classification of GlucoGuide is explained in Chapter 4. Chapter 5 presents the proposed
diabetic lifestyle analytical framework and its empirical and clinical evaluation results. The
clinical data expansion and enhancement process is presented in Chapter 6.
The current research and development status of GlucoGuide spin-off and its future research
objectives are briefly discussed in Chapter 7. The thesis is concluded in Chapter 8.
Chapter 2
Literature Review
In this chapter, we will first discuss the features of diabetic lifestyle data and how they can
be collected and managed via mobile diabetes management systems. Next, we will review
relevant machine learning researches on diabetes-related predictive tasks such as diagnosis and
risk analysis.
2.1 Mobile Diabetes Management System
Nowadays, mobile computing has been emerging as an integral part of daily activities. As
for their application in medical informatics, the technological advances could make medical
services and treatment overcome time and location barriers thus provide ubiquitous, real-time,
individualized medical treatments [21, 22, 23]. In fact, researchers have consistently shown that
such ubiquitous healthcare services could be utilized to enhance the quality of life for people
living with chronic illnesses (such as diabetes, heart disease, cancer, and so on.) [24, 22].
It is well known that the healthcare for T2D is mostly focused on lifestyle changes and self-
management, which are typically managed by increasing exercise, diet modification, and/or
medications/insulins adjustments. If blood glucose levels are adequately lower than certain
levels, medications such as metformin or insulin might not be needed.
In fact, self-management is often a challenge for T2D patients since the control is con-
tingent on numerous complex factors and behaviors. One promising solution is to integrate
ubiquitous healthcare services into diabetes self-management, which could bring more effec-
tive behavioral changes and continuous health monitoring [25].
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2.1.1 Features of Diabetes Lifestyle Data
Health features are aspects of the health conditions that need to be managed and monitored
to best control the chronic illness [26]. Smith and Schatz [26] identify 14 health features,
which are Access to care, Air quality, Blood pressure, Blood glucose levels, Depression, Diet,
Education, Heart rate, Medication, Physical Activity, Respiration, Stress, and Substance abuse
respectively. In terms of diabetes, the most relevant health features of lifestyle data are listed
as follows (other similar health features for diabetes can also be found in [24, 27, 5, 28]):
• Blood Glucose. Blood glucose level is the most important feature and the target variable
for diabetes [25]. This feature is typically collected via either finger-prick glucome-
ter or Continuous Glucose Monitor (CGM) [26, 29].The blood glucose readings can be
transmitted to mobile devices wirelessly or using USB port (some advanced glucometers
follow Bluetooth communication specification made by Continua Health Alliance). To
give an example, Cho et al. [29] employed mobile phone to collect blood glucose mea-
surements. Their results indicated good levels of participants’ satisfaction and adherence
using the mobile technologies to manage blood glucose levels. More conveniently, in the
future, we would image the appearance of wearable sensors measuring glucose levels
without actually taking blood glucose sample, such as Google’s prototype called “Smart
Contact Lens“ for measuring blood glucose levels.
• Diet. Diabetic patients need to delicately monitor carbohydrates intake to avoid abnor-
mal high/low blood glucose level or adjust insulin dosage (mostly for T1D patients).
Other nutrients information such as protein, fat, sodium could also affect their blood
glucose level. Researches have also shown that mobile nutritional support is effective
on diabetes management [26, 29]. Nowadays, diabetes patients could conveniently use
advanced technologies such as barcode scan, Optical Character Recognition (OCR), or
food database searching to conduct diet management. Shortly, with the rapid develop-
ments of advanced machine learning technologies, especially for deep learning, meals
could be recorded via image or voice recognition reliably.
• Physical Activity. Physical activity is typically measured by exercise intensity and dura-
tion [25]. Step counts tracking (pedometer) is another convenient method for estimating
the exercise calories consumption. It is proved that moderate or vigorous exercises could
increase the insulin sensitivity of cells. Thus, keeping track of exercise is important to
T2D patients. Stuckey [30, 31] et al. conducted The Diabetes and Technology for In-
creased Activity (DaTA) study to test the effectiveness of a lifestyle intervention driven
by self-monitoring of blood glucose (BG), blood pressure (BP), physical activity (PA),
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and weight using the mobile devices and wireless communication technologies. Their
research results showed that self-monitoring of the risk factors for metabolic syndrome
(such as hypertension and dysglycemia) and increased physical activity improved the
participant’s cardiovascular disease risk profile. Furthermore, with the help of hourly
step counts information and aerobic step counts, future systems can make more specific
and intelligent recommendations to improve patient’s self-management.
• Access to Care. Access to care mainly refers to the capabilities of being able to commu-
nicate with the health providers in the case of questions or emergency. This can be done
via voice, messages, E-mails between mobile devices and servers [29, 30, 22, 32, 33, 34].
This feature is important for all chronic self-management systems. Patients are motivated
to upload their data since they know that all data could be carefully taken care by health
providers, and they would receive valuable feedback. The location-awareness mobile
device can also report patient’s location to health provider to deal with the emergent
situations.
• Blood Pressure. Blood pressure can be measured using wireless communication enabled
sphygmomanometer or other wearable devices such as Fitbit.
• Weight. Weight is normally related to BMI measurement. Bluetooth-enabled scales can
conveniently record weight data and communicate with mobile phones.
• Education. Education is important for diabetes patients since self-management involves
many complex factors and most diabetic patients lack such knowledge. Mobile devices
have been proven very useful in this area [26]. However, according to the best of our
knowledge, personalized and real-time education is still a big challenge and largely un-
explored.
• Substance abuse. Substance abuse normally refers to tobacco and alcohol. Mobile de-
vices could use message, reminder, or alert functionality to encourage smoking cessation
and reduction in alcohol.
Current mobile diabetes systems are designed to facilitate the management of these health
features. On their clinical effectiveness, Liang et al. [35] reviewed 22 clinical trials that as-
sessed the effect of mobile phone intervention on blood glucose control of patients with dia-
betes. Most results show that significant reduction in glycosylated hemoglobin A1c values and
/ or other health outcomes in diabetes patients when comparing the mobile phone intervention
group with the control group. We list several landmark research papers and clinical trials which
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represent the typical research methodologies and evaluation procedure of ubiquitous diabetes
management research:
• Tang et al. [27] evaluated an online disease management system supporting patients with
uncontrolled T2D. It is a randomized controlled trial of 415 patients with T2D. Patients
in the intervention group (INT) need to upload their glucometer, nutrition, exercise logs,
and insulin record. Nurses and physicians remotely provide glucose summary report,
personalized text and video, and diet advice to INT group. Its clinical trial results show
that INT group has significantly reduced A1c at six months compared to usual care (UC)
(-1.32% vs. -0.66%). While for the 12 months duration, the difference was not very
significant (-1.14% INT vs. -0.95% UC). According to their analysis, the main potential
reason is that UC group could have stimulated behavioral changes due to “Hawthorne
effect“ (changes influenced by being observed in a study).
• Quinn et al. [5] conducted a similar 3-month study. The INT group received mobile
phone based software which provides real-time feedback on patients’ blood glucose
level, medication regiments, incorporated hypo- and hyperglycemia treatment algorithm
and other requested additional feedback. The system sent computer-generated logbooks
with suggested treatment plans to INT group. They claim that adults with T2D achieved
statistically significant improvements in A1c as well as satisfaction levels.
• Noh et al. [36] designed and developed a web-based ubiquitous information system for
diabetes education. They compared the INT group using this system with conventional
education for diabetes patients. Their results show that blood glucose level and A1c are
significantly decreased over time in the INT group but not in the control group.
• Spring et al. [37] argued that some patients exhibit multiple chronic disease risk behav-
iors. They believe that the current literature provides little information about advice that
can maximize simultaneous health behavior changes. They randomized 204 adults with
observed unhealthy behaviors such as saturated fat and low fruit and vegetable, high
sedentary leisure time, and low physical activity. They were requested to use mobile
devices to record and upload their daily activities. The increase fruits/vegetables and de-
crease sedentary leisure treatments improved more than the other three type of treatments
(P ≤ 0.001). Specifically, daily fruit/vegetable intake increased from 1.2 servings to 5.5
servings, sedentary leisure decreased from 219.2 minutes to 89.3 minutes and saturated
fat decreased from 12.0% to 9.5% of calories consumed.
• In the pilot-controlled clinical trial conducted by Katz and Nordwall [34], they utilized
Bluetooth, mobile phones, and application servers to facilitate the self-management pro-
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cess. More importantly, their system translated scientifically supported knowledge for
chronic disease management into action by providing easily followed daily coaching
using the patients’ data. It is a data-driven system because the feedback messages are
selected by the system based on the patient’s historical data. However, their feedback
is simply generated using domain knowledge and needed human involvement to review
the data and provide personalized feedbacks. We argue that such process is not feasible
when the data scale become large.
We have surveyed state-of-the-art products and applications in the industry. By reviewing their
product specifications, we can conclude that all the health features mentioned above are man-
ageable via nowadays’ mobile technologies and Web technologies. Most recently, IT giants
such as Google, Apple, and Microsoft have also released their mobile health platforms for fit-
ness and chronic diseases managements. Take ResearchKit for an example, which is an open
source framework introduced by Apple to enable efficient lifestyle and clinical data collec-
tion and aggregation. Researchers can easily create visual consent flows, conduct real-time
dynamic active tasks and survey using a variety of customizable modules provided by Re-
searchKit. Also, since ResearchKit works seamlessly with HealthKit, allowing iOS apps that
provide health and fitness services to share their data with each others. Researchers thus can
access even more relevant lifestyle data for their studies, such as daily step counts, calorie use,
and heart rate, etc.
Although the clinical trials and products mentioned above show that it is technically feasi-
ble to improve diabetes self-management using mobile devices and Web technologies. How-
ever, most systems are very similar in their functionalities and implementations, and there
are obvious gaps between the evidence-based recommendations and their current implemented
functionalities. Furthermore, in spite of the effectiveness of these clinical trials, most of them
are not cost-effective. Participants in the clinical trials still take large efforts to synchronize
their lifestyle data. Health providers on the server-side need to routinely check and review pa-
tients’ data and provide feedback. As such, we believe it is still very challenging to design and
develop an intuitive, intelligent, and interactively ubiquitous diabetes management system.
Predictive models, as an important component of machine learning, could be utilized to
facilitate the data processing and allow patients and their health providers interact in a more
convenient and timely manner. Researchers have been exploring the application of predictive
models in diabetes domain for nearly two decades. In the next section, we will discuss how
predictive modeling can be applied to diabetes diagnosis and risk analysis.
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2.2 Diabetes Risk and Diagnosis Using Predictive Modeling
Predictive modeling, also can be called supervised learning, is a process used in predictive
analytics to create one or multiple models with forecasting probabilities and trends. It has
two main components: Classification and Regression. Classification aims to categorize data
entries into discrete class labels (e.g., Spam vs.Non-Spam), with minimum classification errors
subject to applicable constraints. Regression tries to predict continuous values such as stock
price, temperature, etc. The overall performance of regression is usually measured by mean
absolute error or mean squared error.
Diabetes risk and diagnosis prediction are typically considered as classification tasks, clas-
sic classification framework such as Support Vector Machine (SVM) [6, 10, 15], Decision
Tree [12], RandomForest [14], Neural Networks [9], Naı¨ve Bayes [11] are widely employed.
Training datasets are focused on clinical diagnoses and patient’s profile data, including pa-
tients’ family history, age, race and ethnicity, weight, height, waist circumference, body mass
index (BMI), hypertension, diagnosis code, etc. Once classification models are well-built, it is
clearly to predict and identify the important rules and features causing diabetes disease.
Yu et al. [10] built SVM models on patient data from the 1999-2004 National Health and
Nutrition Examination Survey (NHANES). They designed two classification schemes: Clas-
sification Scheme I (diagnosed or undiagnosed diabetes vs. pre-diabetes or no diabetes) and
Classification Scheme II (undiagnosed diabetes or prediabetes vs. no diabetes), and achieved
receiver operating characteristic (ROC) curve, were 83.5% and 73.2%, respectively. Nahla et
al. [15] used an additional explanation module, turning the “black box“ model of an SVM into
an intelligible representation (ruleset). Evaluation results on a real-life diabetes dataset show
that their intelligible SVMs achieve with the prediction accuracy of 94%. Polat et al. [6] have
used Generalized Discriminant Analysis to discriminant features between healthy individuals
and patients (diabetes). Then, they built LS-SVM to classify diabetes dataset. The proposed
system called GDALS-SVM and obtained 82.05% classification accuracy using 10-fold cross
validation. Similar research classification works have also been found in the literature using
Decision Tree [12], Artificial Neural Network (ANN) [9], and Naı¨ve Bayes [11].
Li and Zhou in [14] argued that if we can learn models in the presence of a large amount of
undiagnosed samples, the heavy labeling burden on the medical experts could be released.
They proposed a semi-supervised learning algorithm named Co-Forest. It extends the co-
training paradigm by using a well-known ensemble method named Random Forest, which
enables Co-Forest to estimate the labeling confidence of undiagnosed samples and produce
the final hypothesis easily. Their diabetes case studies show that undiagnosed samples were
helpful in building computer-aided diagnosis systems, and their model was able to improve the
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performance via learning only a small amount of diagnosed samples by utilizing the available
undiagnosed samples.
Although the diabetes diagnosis and risk analysis are well-studied using predictive models,
we argue that more short-term and actionable predictive tasks could be performed. For exam-
ple, predictive models could be used to learn the knowledge from dietitians and then provide
food guide for T2D patients. More advanced, given sufficient training data, predictive models
should be able to discover which lifestyle factor has the largest influence on the abnormal blood
glucose level.
In the next chapter, we will further discuss our research questions regarding the challenges
and barriers of current diabetes self-management and how predictive models can be applied to
solve them.
Chapter 3
Overview of the GlucoGuide System
In this chapter, we will further discuss the main challenges of current mobile diabetes manage-
ment systems. Next, we will compose our research questions regarding the solutions to these
challenges via applying machine learning technologies and mobile computing.
3.1 Challenges
Based on the remarks of literature review and our preliminary studies, we think there are two
main challenges for current mobile diabetes management systems. The first one is the com-
plexities of lifestyle data input. The second one is the lacking of evidence-based lifestyle
recommendation for patients to effectively stabilize their blood glucose. These two issues are
in fact connected and affected by each other. The ease of data recording enables more and
better quality of training data from patients for applicable predictive models to generate better
results. On the other hand, the irrelevant or inaccurate data input will certainly commit errors
and noise to further data analysis. The output of predictive models, as potential personalized
patterns or knowledge, could be incentives for users to record more qualified data.
Most lifestyle data nowadays can be automatically captured via a variety of sensors (such
as glucometers, pedometers, blood pressure monitors, etc.). Smart wearable sensors like Fitbit
products can also collect comprehensive health data about your body, especially for your phys-
ical activities. However, for diabetes patients, logging diet and glucose level are still relatively
difficult. As discussed before, machine learning technologies such as most recent deep learning
can be utilized to help patients with diet and blood glucose input. For example, it is possible
now that patients can take pictures of a food item, and that food item can be recognized us-
ing deep neutral networks. Then, we can query the meta-data about that food item in a food
database to get its nutrition information.
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How to tackle the second challenge is the focus of this thesis work. We aim to collect
and analyze lifestyle data using predictive models. Based on the model outcomes, evidence-
based, personalized, and timely recommendations could be generated to guide patients’ self-
management practices. Such recommendations are closely related to patients’ data, thus can
effectively evaluate their performance and help patients creating more specific and personalized
action plans. On the other hand, recommendations can also be viewed as incentives of data
recording and motivate patients to record and upload more qualified data.
3.2 Research Questions
We set the focus of this thesis on T2D patients since it comprises more than 90% of the diabetic
population [25]. Thus, improving the treatments of T2D is significant to patients’ condition
and our society. We believe predictive models could be applied to the two most important and
complex components of T2D self-management: 1) Diet management and 2) Blood glucose
monitoring and predictions. Specifically, predictive models could be used to analyze food
data and categorize each food item into different recommendation levels for patients. More
intelligently, predictive models could also be used to predict blood glucose level and identify
what factor(s) causes abnormal blood glucose levels. Since T2D patients usually do not use
CGM devices, our blood glucose prediction task will focus on lifestyle data and fingerstick-
based blood glucose samples.
As such, we propose three research questions or hypotheses as follows:
• Can we use classification models to generate real-time food guideline to help pa-
tients proactively manage their diet?
• Can we predict T2D patients’ blood glucose level merely based on lifestyle data and
discrete fingerstick-based blood glucose samples?
• Can we provide clinically effective lifestyle recommendations based on the outcomes
of blood glucose prediction?
To answer these research questions, we propose, build, and evaluate an intelligent mobile di-
abetes management system, called GlucoGuide for T2D patients. GlucoGuide conveniently
aggregates varieties of lifestyle data collected via mobile devices, analyzes the data with pre-
dictive models, and outputs recommendations.
In the next section, we will present the architecture of GlucoGuide.
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3.3 The GlucoGuide Solution
GlucoGuide contains three sub-systems, as shown in Figure 3.1, including the 1) Lifestyle data
collection and preprocessing, 2) GlucoGuide mobile clients, and 3) GlucoGuide Engine. Their
design and development processes involve many up-to-date technologies.
The GlucoGuide mobile clients has been designed and built on the latest Google Android
and Apple iOS systems, aiming to provide excellent user experience powered by our well-
designed user interface and information visualization technologies. One design goal here is to
reduce the burden of lifestyle data input in GlucoGuide. For example, we have been designing
and implementing the camera-based auto logging of food items and glucometer readings. It
acts as a bridge connecting patients and GlucoGuide Engine. The mobile clients collect raw
lifestyle data, preprocess and upload them securely to GlucoGuide Engine where data analysis
takes place. Patients can also use the mobile clients to receive and review recommendations,
setup different kinds of reminders, etc.
Figure 3.1: GlucoGuide architecture
The GlucoGuide Engine, consisting of various computing servers, can also be regarded as
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a computer cloud. It consists of a centralized database, machine learning engines, and a web
portal, which allows patients and our health teams to log-in to review the visualized health data
and online logbook. The core function of GlucoGuide Engine is to analyze the uploaded data
and generate recommendations based on patients’ data using predictive models.
3.3.1 Food Classification
The first type of recommendation is proactive diet guideline. Among all the components of
self-management, the most important and complicated part is the diet management, requiring
T2D patients restrict and accurately count the amount of carbohydrates, protein, fat, and so
on [25]. Since there are diverse foods available at various places (supermarket, restaurant,
home-made, etc.), for most T2D patients (especially for prediabetic patients) often feel frus-
trated and troublesome in composing effective and diabetic-friendly meal plans to achieve their
daily carbohydrates goals. They do need assistance to help them determine what kinds of food
items are suitable for their diabetic conditions or not. Ideally, patients should be able to query
concerning the recommendation of any food items in nearly real-time.
We model this problem as a binary or multinomial classification problem, predictive models
for classification thus can be employed to categorize any food items into its corresponding
recommendation level (such as this food item should be chosen more often or chosen less
often).
To achieve this goal, we first construct a comprehensive food feature vector via extracting
nutrient and textual features from training food datasets. Then, three food recommendation
labels: “Choose More Often“, “In Moderate“, and “Choose Less Often“ are designed as class
labels. Next, we explore and evaluate several state-of-art predictive models with different bi-
ases and structures for the food classification task. According to the results of our empirical
study, we find that tree-based classification models outperform others in this practical problem
context. The best prediction accuracy of tree-based models could reach to around 95%, which
is a very promising result indicating the proposed idea of using classification model for diabetic
food classification is empirical effective. See Chapter 4 for details.
3.3.2 Lifestyle Recommendation
The second type of recommendation is related to lifestyle activities (such as diet, exercise, etc.)
and derived from the outcomes of blood glucose prediction.
If the updated lifestyle data indicate that a patient is in emergent or dangerous situations,
such as abnormally high or low blood glucose levels for longer period of times, GlucoGuide
provides immediate assistance to the patient, as well as alerts to the healthcare providers.
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If patients’ lifestyle data do not present emergent or dangerous situations as above, those
data will be accumulated. A few times in a week, a proposed predictive framework called
temporal-weighted regression (TWR) will be deployed on our server to discover correlations
between the recent lifestyle data and the blood glucose levels for each patient. Such correla-
tions will be framed in natural language templates (aligned with CDA guidelines) and sent to
patients’ mobile devices as recommendations. As patients’ data are different, the recommen-
dations are also personalized.
To evaluate the performance and the clinical effectiveness of this framework, we conducted
a three-month clinical trial on human subjects. Due to the high cost and complexity of trials on
human, a small but representative subject group was involved. We empirically evaluated the
TWR framework and showed that the prediction performance of TWR is similar to the state-of-
the-art [16], using the collected lifestyle data and discrete blood glucose samples. Furthermore,
two standard laboratory blood tests for diabetes were conducted on patients before and after
the trial. The results were quite remarkable with over 90% confidence levels in the significance
test. In sum, GlucoGuide could be amounted to turning an early diabetic patient to be pre-
diabetic, and pre-diabetic to non-diabetic, after a three-month trial. See Chapter 5 for details.
Chapter 4
Food Classification for Diabetes
Effective diet management requires T2D patients restrict and accurately count the amount of
carbohydrates, protein, fat, and so on. T2D patients (especially for prediabetic) often feel
frustrated and troublesome in composing efficient and diabetic-friendly meal plans to achieve
their daily carbohydrates goals.
Most diet management tools for T2D patients only provide basic meal recording and nutri-
ent visualization functionalities, such as food database searching, calories counting, etc. The
primary barrier of these tools is the lack of diet guideline/assistance for T2D patients, which
is typically provided by dietitians with a costly (either patients’ own time costs and/or gov-
ernment/insurance company medical costs) and time-consuming consultation process. In fact,
T2D patients do need such assistance in a more convenient and timely manner to help them
decide what kinds of food items are suitable for their diabetic conditions or not, especially for
those home-made food items.
As far as we are concerned, predictive models can be utilized to overcome this challenge
and proactively guide patients in their food selection. More specifically, they can be employed
to determine whether a food item should be chosen more often or less more.
We define this problem as a multinomial classification task. As for this problem, we first
construct a comprehensive food feature vector and extract nutrient and textual information from
two different training food databases. Then, three food recommendation labels: “Choose More
Often“, “In Moderate“, and “Choose Less Often“ are designed as class labels.
Next, we explore and evaluate several state-of-art predictive models with different biases
and structures for the food classification task. According to the results of our empirical study,
we find that tree-based models outperform others in this practical problem context. The best
prediction accuracy of RandomForest reaches around 95%, which is a very positive result indi-
cating the proposed idea of using classification models is promising. Furthermore, we have also
explored the feature importance and instance proximity matrix of generated RandomForest.
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More details about this empirical study can be found in Section 4.3.
We have deployed the fine-tuned classification model in the GlucoGuide mobile clients,
along with a comprehensive food database and food UPC scanning technologies. As such,
T2D patients could ubiquitously and conveniently access any food items in the database with
the help of model-generating food recommendation labels.
The rest of this chapter is organized as follows: Section 4.1 describes the design principle
of the proposed food classification tool, Section 4.2 presents the construction of food feature
vector, Section 4.3 describes the classification models selection, evaluation methodology, and
its results. The last two sections discuss the relationships to previous works and conclusions.
4.1 Design Principle
Figure 4.1: Patients nowadays can easily use mobile devices to get the detailed information
about food items (nutrient and textual information). Then, our classification model can gener-
ate recommendation labels on each food item.
The design principle of our food classification tool is shown in Figure 4.1. With the assis-
tance of many advanced HCI technologies, patients nowadays can use their mobile devices to
first obtain the meta-data of food items (UPC code, entities, keyphrases, categories, etc). Then,
we can use the meta-data to query our food database to get the specific nutrient and textual
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information about the food items. By utilizing well-trained classification models, our tool can
output recommendation labels for users.
Numerous food databases are available in the health and nutrition industry. They typi-
cally have different characteristics and scales in terms of dimension and volume. For example,
Canadian Diabetes Association (CDA) maintains a food database with only three nutrition fea-
tures while a large scientific food database provided by Canadian Nutrition File (CNF) has
more than 150 nutrition features. However, most of these food databases do not provide food
recommendation to T2D patients.
The food database used in our tool contains 65,000+ popular North-American food items
(a commercialized food database), and it is a very comprehensive database with each item
has its food name, category, sub-category, and 18 nutrient attributes. Also, this is the target
dataset for the food classification task. Patients can search this food database to record detailed
information about their diet. To facilitate the database search, we designed several interactions
for users to input food keyword. They can type the keywords (such as “bagel“ or “starbucks
coffee“) using a soft keyboard or using the voice dictation to speak out the keywords. More
conveniently, we employed barcode scan technologies to help patients scan the food UPC code
(Figure 4.2) and retrieve food nutrition and textual information.
Our training datasets are two diabetic food databases, each food item in the databases has
been labeled by dietitians and nutrition experts. In particular, one training dataset is provided
by CDA [2] containing around 500 most common food items in Canada. CDA classifies each
food item to be “Choose More Often“ or “Choose Less Often“ (e.g., binary labels) as a food
guidance for diabetic patients. Another one is provided by Food Picker TM containing more than
13,000 food items. Each food item has three class labels: “Choose More Often“ , “In Mod-
eration“, or “Choose Less Often“ (e.g., muti-nominal labels). Note that these two databases
are collected from two different data sources, with different features, food items, and label-
ing strategies. Thus, the classification model to be learned could absorb more comprehensive
domain knowledge via such data aggregation.
Next, we construct the food feature vector for classification. Ideally, a large feature vector
is desirable to characterize food items comprehensively. Based on the properties of food, we
defined two types of features: nutrition features and textual features.
In particular, nutrient features characterize a food item via its nutrition attributes, such as
carbohydrate, fat, protein, sodium, etc., which are costly but accurately calculated by numerous
nutrition laboratories worldwide. Most food databases provide nutrient information by default.
The second feature is related to a food item’s textual information, such as category, subcategory,
name, etc. This kind of feature can also be very useful for classification especially when the
nutrition information is not available. How the textual features can be extracted and integrated
4.1. Design Principle 21
will be described in Section 4.2.
Once the training datasets are prepared, we then need to select the classification model(s)
for the classification task via empirical evaluations. The best fit model will be deployed on
GlucoGuide mobile clients to classify food items.
Figure 4.2: Scan the barcode on a salad product to get its UPC code, then use the UPC code to
retrieve nutrition and textual information from UPC database. Our classification model tries to
classify this food item based on the nutrition and textual information.
With this tool, patients can conveniently track and review their daily nutrition intakes. More
intelligently, the embedded model can guide patients in their food selection. Here is an example
illustrating how T2D patients could use this tool. Suppose a patient is purchasing groceries in
a supermarket and having difficulties in choosing a food product. He/she can then open our
tool to scan the barcode of the product (such as Dole Salad) and get its nutrient and textual
information. Then, our model can output the color-coded class label to guide the patient about
this food, as shown in Figure 4.2.
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4.2 Textual Feature Extraction
We believe that a food item can not only be classified by its the nutrient features but also by its
textual features as supportive information. As such, we define the full feature vector of a food
data instance as:
F = [N ,T ]
where N represents the nutrition feature vector and T represents the textual feature vector.
Since the values of nutrition featureN are already known in both training food databases, how
to extract textual features and generate T is the main component of our feature extraction task.
In particular, nutrition features are obtained straightforward from the nutrition label. Once
we have obtained the nutrition features of food items, we can utilize some state-of-art clas-
sification models without taking any domain knowledge into consideration. On the contrary,
constructing the textual features do require domain knowledge and specifically-designed fea-
ture extraction strategies.
We choose to extract textual features mainly from the CDA food database since it is an
official food database [2]. In other words, it provides the most authoritative textual information.
Given the food vocabulary vector V of CDA’s training food database, each dimension cor-
responds to phrase wt from V . Typically, the dimension of the vocabulary is large. To reduce
the dimension size, we replace it with a subset of keyphrases vector K. Note that we only use
1-word or 2-word keyphrases such as “whole wheat“, “low fat“, and “sweeten“, etc., appear in
the food name.
The next step becomes how to extract the important keyphrases existing in the food vocab-
ulary vector V . We proposed two approaches to generate the keyphrases vector K to achieve
this goal.
4.2.1 Domain Knowledge based Extraction
Human labeling is an effective approach to extract keyphrases, although it could be very time-
consuming and expensive. Thus, with the assistance of our medical team, we identified a
human-labeled keyphrase list kh, h ∈ {1, . . . ,H} via thoroughly and delicately searching in
CDA literature and its official diet guideline [2].
However, the human extracted keyphrase list could not be comprehensive enough. To en-
rich the human-labelled keyphrase list Kh, machine learning based feature extraction will also
be used.
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4.2.2 Machine Learning based Extraction
We have employed the Naı¨veBayes learning to extract the keyphrases, which is widely used
in document classification. The influence of each phrase in a food item was measured with
respect to its class to discover the most important/informative keyphrases.
The training food items in CDA database provide binary class labels. To simplify the
format, we define the class “Choose More Often“ as c0 and “Choose Less Often“ as c1. We
treat each food item i as a document di, which is a binary vector over the vocabulary V . Then,
we characterize the probability of food item with its class using multi-variate Bernoulli event
model [38, 39] (following the Naı¨ve Bayes assumption):
P(di|c j) =
|V |∏
t=1
(BitP(wt|c j) + (1 − Bit)(1 − P(wt|c j))). (4.1)
where Bit ∈ {0, 1} indicates whether phrase wt appears at the dimension t of food item di. Then,
we build a Naı¨veBayes classifier attempting to find the class c j that maximize the probability
P(di|c j).
Given the CDA training data D = {d1, d2, . . . , d|D|}, we calculate the binary-class conditional
phrase probability as:
P(wt|c j) =
1 +
∑|D|
i=1 BitP(c j|di)
2 +
∑|D|
i=1 P(c j|di)
. (4.2)
Note that a Laplacean prior in Equation 4.2 is calculated in case some phrase counts are zero.
Having such phrase probability, we define a keyphrase selection metric Qt as:
Qt =
P(wt|c0)
P(wt|c1) . (4.3)
By intuition, Qt indicates how likely the phrase wt associated with class c0 compared to class c1.
In another phrase, any phrase with a large Qt value means it is a class discriminative keyphrase
with respect to classification. We thus choose phrase wt as a candidate keyphrase km (note that
each keyphrase here contains only one phrase) if its Qt is beyond a predefined threshold (5th
quintile was chosen in this experiment). By iteratively performing the above calculations, we
can build a machine-generated keyphrase list km,m ∈ {0, . . . ,M}.
4.2.3 Merge Textual Features
The last step is to append the extracted keyphrase vector Km list to the existing human labeled
keyphrase list Kh. We first compare each keyphrase km with all human labeled keyphrase Kh.
If a keyphrase km is “similar“ enough to an existing keyphrase kh, we just ignore the keyphrase
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and move to the next one on the list. Here we employ a metric Q(km, kh) defining such similarity
between km and keyphrase kh:
Q(km, kh) = 1 − L(km, kh)lmax(km, kh) , 0 ≤ Q(km, kh) ≤ 1. (4.4)
where L(w, k) is the Levensthein distance [40, 41] between km and kh. The lmax(km, kh) is the
maximum string length between km and kh. As such, for each phrase km, we calculate the
maximal similarity Q(km, kh)max, h ∈ {1, . . . ,H}. If Q(km, kh)max is below a predefined threshold,
we will consider km as a newly discovered keyphrase and append it to the human-labelled
keyphrase list Kh.
4.3 Generating the Training Dataset
Carbs Pro ... Fat 0 0 0 ... 0
17 Nutrition Features (filled values)
216 Keyphrase Features (all start with zero)
Textual value calculation
(Levensthein distance calculation)
Carbs Pro ... Fat k1 k2 k3 ... kT
Figure 4.3: Aggregating the nutrition features and textual features, and calculating the values of textual
features using Levenshtein distance.
After merging the two keyphrase lists Kh and Km, we can generate the textual feature vector
T . For each food item in the training databases, we combine the textual feature T to the
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Figure 4.4: Classification accuracy for each model using 3 different feature vectors
nutrition feature vector N and obtain the complete structure of feature vector F, as shown in
Figure 4.3.
The complete feature vector F has 17 nutrient features and 216 textual features; each nu-
trition feature Ni represents a nutrient element and each textual feature T j, (0 ≤ T j ≤ 1)
represents the keyphrase similarity. The value of T j is calculated by measuring the maximal
similarity between each keyphrase feature T j and all the subsequences whose length less than
three words of the food name. Such calculation process is similar to Equation 4.4.
After the feature extraction and data preprocessing, the training dataset (including 233 fea-
tures and 13,260 data instances) is ready for the classification task.
In this section, we will discuss the classification model selection and evaluation.
4.3.1 Evaluation Methodology
4.4 Model Selection and Evaluation
Different classification models have different cost functions, structures, and biases. As far as
we are concerned, choosing the best fit model for the food classification task is an iterative
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and experimental process. Given the characteristics of this food classification problem, we
have chosen five popular classification models as candidates: J48 [42], RandomForest [43],
LibSVM [44], Naı¨veBayes [45], and LogisticRegression [45].
Next we will describe the experimental settings for these classification models. Finding
the optimal parameters for each model is a necessary but time-consuming process. For each
model, we conduct ten fold cross-validation first with different parameter settings to ensure it
could reach the potential on this dataset. For example, all tree-based models were pruned with
confidence level set to 0.25 [42], the number of trees in the RandomForest was set to 10, the
kernel of LibSVM was set to the RBF kernel, the standard classification accuracy was selected
as the main performance measurement. etc.
In addition, we evaluate each model using three different feature sets (i.e., textual features
T , nutrition features N , and comprehensive features (T + N)). As such, we can empirically
evaluate the different combinations of feature vectors and classification models then find the
best one.
After the ten folder cross-validation with optimal parameter tuning, we obtain the model
accuracies, as shown in Figure 4.4. We can see that all models have the worst classification
accuracy using only the textual feature vector (yellow bars) and have much better accuracy
using the nutrition feature vector (red bars). Furthermore, by integrating the textual and nu-
trition feature vectors, the accuracy is significantly improved for almost all models except for
RandomForest (blue bars). The classification precision and recall have the similar trend as the
overall accuracy thus we do not depict them in here.
Note that J48 and RandomForest outstand from other candidates on this dataset. They are
able to obtain around 95% prediction accuracy using the combination of nutrition and textual
features (Figure 4.4). One possible explanation could be that the tree models are the most
suitable model for mimicking the dietitians’ reasoning/classification process. Also according
to Kotsiantis [46], tree models are sequential models, which logically combine a sequence of
simple tests; each test compares a numeric attribute against a threshold value or a nominal at-
tribute against a set of possible values. In that way, they can closely resemble human reasoning
and are easy to understand. As a result, the tree models have been discovered to be the best
model for the food classification task in this problem domain.
Also in this experiment, we find that textual features based food classification is also
promising, as it can obtain about 80% classification accuracy using tree models. Thus, we
believe that textual features based classification could be useful especially when the nutrition
features are not accessible or available. For example, if the nutrition information of a food
item is unknown, patients can still use modern HCI technologies such as barcode scan or OCR
to obtain the textual information (name, categories, brand names, etc.). Tree models can still
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conduct classification tasks on the text-only test instances with reasonable good prediction ac-
curacy.
In sum, in this empirical study, we find that RandomForest model is the best-fit model
among all the candidates. Thus, we can conduct further empirical studies using the RandomForest
model.
4.5 Food Classification Using RandomForest
RandomForest [43] is a very powerful and comprehensive classification model. It is a combi-
nation of randomly generated classification trees. For each test instance, each tree in the forest
generates a class label and the final class label is the one gets the most “vote“. RandomForest
has many advantages, including the generation of an internal unbiased estimate of general-
ization error (out-of-bag error), feature importance estimation, case proximities, and handling
large scale of data, etc.
4.5.1 Model Tuning
In RandomForest, each tree is generated using a different bootstrap sample from the original
data sample. About one-third of the cases are left out of the bootstrap sample and not used in
the tree construction as the test set. In this way, a test set classification is obtained for each
case in about one-third of the trees. The proportion of times the estimated class is not equal
to the true class averaged over all cases is called the out-of-bag (OOB) error estimate. As
such, RandomForest typically dose not require cross-validation or separate test datasets to get
unbiased performance estimation [43].
RandomForest has two importance parameters to be tuned. The first one is the number of
features randomly sampled as candidates at each split, and the second parameter is the number
of the trees in the forest.
We used grid searching to tune the first parameter, i.e., the number of feature candidates,
started with 15. We set the inflation/deflation rate to 1.5. For each tuning iteration, the OOB
error estimation is compared with the previous iteration until converged (improvement less
than 0.05). In this experimental context, we find that the optimized feature number is 73.
As for tuning the number of trees in the forest, we investigated the OOB with 50, 100,
250, 500, 1000 trees, as shown in Figure 4.5. The feature candidate number was set to 73,
as discussed above. As we can observe from Figure 4.5, the OOB error rate converges at 100
trees. Thus, we can choose the optimized tree number to be 100 for the future experiments.
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Figure 4.5: OOB error rate with different tree numbers in the forest
With the fine-tuned RandomForest, the classification error rate is 5.37%, meaning a very
promising 94.63% classification accuracy. To further estimate the classification error rate for
each class, we output its confusion matrix, as shown in Table 4.1. We can see from the matrix
that although the class distribution of original data sample is not well balanced, the estimation
error rates for each class are still similar. As such, we think no imbalanced classification
technologies such as cost matrix or class weighting are required for this food classification
task.
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Figure 4.6: Feature importance with respect to mean accuracy decrease.
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In Moderation Less Often More Often class error
In Moderation 6317 282 50 0.04993232
Less Often 336 5277 8 0.06119907
More Often 33 5 952 0.03838384
Table 4.1: Classification confusion matrix
4.5.2 Feature Importance
The dimension of our food feature vector is 233. To increase the interpretation, we want to
discover which features have the large influence on prediction results. In RandomForest, the
feature importance of feature m is calculated by first randomly permute its values in the OOB
cases and put these cases down each tree in the forest. Then we subtracted the number of votes
for the correct class in the variable-m-permuted OOB test cases from the number of votes for
the correct class in the untouched OOB cases. The average of this accuracy decrease over
all trees in the forest is the raw importance score for the variable m [43]. We depict the top
important features in Figure 4.6, we can see that among all the features, the most importance
nutrient features are: Saturated Fat, Calories, Sodium, Total Fat, Sugars, Protein, Carbohydrate,
and Fiber. The most discriminative 1-word keyphrases are “wheat“, “light“, “grains“, “fruit“,
“milk“, “sugar“, “cheese“, “diet“, “dressing“, “yogurt“, “unsweeten“, “free“, etc.
Note that the important features we discovered in this empirical study are consistent with
the nutrient and diet guideline provided by CDA [25] and Health Canada. This finding also
validates the effectiveness of our classification model.
4.5.3 Prototype
RandomForest can also be used to calculate a N by N (N is the total number of data instances)
proximities matrix [43]. After a classification tree is built, we can put all of the data instances
down the tree. If cases k and j are in the same leaf node, their proximity in the matrix will be
increased by one. The final proximity matrix is normalized by the total number of trees in the
forest.
After the proximity matrix is calculated, we can further obtain the “representative“ in-
stances on each class label. Such instances are called Prototype [43], which is a similar concept
to centroid in clustering but generated in a supervised manner.
We calculate food item prototypes (nutrient features only since they are much more impor-
tant) with respect to each class, as shown in Table 4.2. We can see that some features such
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Choose More Often In Moderation Choose Less Often
Calories Total (g) 5 110 270
Total.Fat. (g) 0 1 14
Saturated.Fat (g) 0 0 6
Cholesterol (mg) 0 0 30
Sodium (mg) 20 380 460
Carbohydrate (g) 1 20 27
Dietary.Fiber (g) 0 3 2
Sugars (g) 0 2 5
Protein (g) 0 0 8
Vitamin.A (%) 0 0 6
Calcium (%) 0 4 10
Iron (%) 0 8 6
Table 4.2: Food classification prototypes
as Calories, Sugars, Carbohydrate, Sodium, and Total Fat increase monotonically with class
labels.
Other features such as Fiber and Iron do not follow such pattern. This inconsistency could
be caused by low measurement granularity. Any value less than 1g or 1% will be given zero
value in the data instance. Thus, the fiber value for “Choose More Often“ prototype is in fact
unknown due to the granularity. However, if we output the fiber calories breakdown ratio in
total carbohydrates, we can see that the ratios are 0%, 15%, and 0.07% respectively. Still, it
is reasonable to assume that in healthy foods, the percentage of fibers in total carbohydrates
should be much larger than the unhealthy foods. We think that the fiber percentage possibly
also increase monotonically with class labels.
In sum, features like fiber percentages, as well as other calories breakdown ratios, could
be added in the food feature vector as new features to improve the classification accuracy. We
could collaborate with nutrition experts to discover more such features. More food feature
engineering will be one of our future work.
4.6 Relationship to Previous Work
Food labeling/classification for T2D diabetes is an interdisciplinary area and has been research-
ing for several decades. In this area, the glycemic index (GI) is the most impact food labeling
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system created on 1980 [47].
More specifically, GI is a measurement of the power of foods to raise blood sugar glucose
levels after being eaten. Food items with a high GI value contain rapidly digested carbohydrate,
which causes a rapid rise and fall in the level of blood glucose. In contrast, food items with
a low GI value contain slowly digested carbohydrate, which causes a gradual, relatively low
rise in the level of blood glucose. The GI values of foods must be measured using valid and
expensive scientific methods [47].
Sydney University GI Research Service (SUGiRS) provides a reliable commercial GI test-
ing laboratory for the local and international food industry [48]. They created GI values of
more than 2500 foods. However, as far as we are concerned, GI system is still too complicated,
expensive, and not user-friendly for general T2D diabetes.
Guiding Star [49] system is another nutrition guidance system aiming to score the food
items in Canada’s most popular supermarkets manually. Its food labeling is a collaborative
process between grocery retailers and a panel of nutrition experts. However, as far as we are
concerned, the classification rules of Guiding Star system are all fixed thus not data-driven,
which makes its scalability is very low. Moreover, its guideline is designed for general people,
which is different from the diet guidelines for people with T2D.
Compared to the previous works, our work proposed a more flexible and reliable frame-
work for this problem, which makes the following contributions. Firstly, the concept itself is
novel, to the best of our knowledge, this work is the first attempt integrating machine learning
technologies into T2D patients’ diet management. The second contribution is that we have
designed an effective approach to extract a comprehensive food feature vector, including both
nutrient and textual features, for the classification task. The third contribution is that we find
that the tree-based classification models (J48, RandomForest, etc.) can archive the best per-
formance in this problem context. We also evaluate the performance of tree-based models
using the different feature and instance sets. Furthermore, the optimal features are discovered
after the evaluation. The last contribution is that the deployment of the classification model
on GlucoGuide mobile clients, allowing patients to access food database and the embedded
classification model conveniently and ubiquitously.
4.7 Food Classification Future Works
Even with the help of barcode scanning and food database searching, food recording could still
be difficult. Ideally, when a meal is taken pictures by the camera of patients’ mobile devices,
labels and nutrients of this meal are automatically analyzed by images pattern recognition
algorithms. Such automatically food recording process would greatly enhance the usability and
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user experience. However, image-based food information retrieval is extremely challenging in
generic objects recognition due to its large varieties in spatial, shape, color, texture features, etc.
Due to these complex characteristics, traditional multinomial classification solutions would
cause large intra-class errors in practical settings.
Deep learning frameworks could be applied to classify food items based on food photos.
In fact, the basic ideas of deep learning appeared about two decades ago. However, due the
limitation of computational power, modeling a deep Artificial Neural Networks (ANN) would
be extremely time-consuming (normally with the unit of years). As such, researchers at that
time only applies “shallow“ ANN but still achieve state-of-art results. In 2011, Andrew Ng
founded the Google Brain project at Google, which developed deep ANN using Google’s dis-
tributed compute infrastructure. Among its notable results was a neural network trained using
deep learning algorithms on 16,000 CPU cores, that learned to recognize higher-level concepts,
such as cats, after watching only YouTube videos, and without ever having been told what a
”cat” is. The project’s technology is currently also used in the Android Operating System’s
speech recognition system.
Although deep learning can automatically learn the hierarchical feature representations and
achieve very promising precision, it normally needs a huge amount of training data. In another
word, if data are limited, the performance of deep learning might not be able to outperform
some simple learning algorithms. Also, in deep learning, the time complexity is also big,
to assure the feasibility of the algorithm, high-quality distributed computing and hardware
supports are required.
The computer vision team of GlucoGuide has been researching and developing mobile
camera-based food recognition for more than two years now. We have applied Convolutional
Neural Networks (CNN), a state-of-art deep learning approach, to recognize the food item
through parameter optimization on GPU. We constructed a dataset composed of 49,360 food
images of 40 types most popular Canadian and American food and trained a Convolutional
Neural Network classifier for food recognition. Our test results show promising accuracy rates
(top 1 accuracy rate: 78%; top-five accuracy rate: 93%). With the aid of food recognition
technique and high-end GPU computers, users are able to conveniently log their diet data just
by snapping a photo and getting an estimate of the nutrition information in less than one second.
4.8 Conclusion
In this chapter, an intelligent food classification tool is proposed using classification mod-
els and mobile computing, aiming to facilitate T2D patients’ diet management and provide
food recommendations. We have collected two training food database with true labels and
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extracted a comprehensive feature vector from them. Extensive empirical studies have been
conducted to explore among different types of classification models. The studies indicate that
the RandomForest is the best-fit model with around 95% prediction accuracy. The well-trained
model is also deployed on GlucoGuide mobile clients to help T2D patients conveniently man-
age their diet.
This tool has proved empirically effective to provide proactive food guidelines allowing
T2D patients to make decisions on their food selection beforehand. In addition to food recom-
mendation, we also want to provide recommendations regarding patients’ historical lifestyle
activities. To achieve this goal, we have designed and implemented a lifestyle recommen-
dation framework to generate data-driven recommendations helping T2D patients to stabilize
their blood glucose. We also conduct a clinical trial to collect training data and evaluate its
clinical effectiveness. The details of this framework and its evaluation results will be presented
in the next chapter.
Chapter 5
Lifestyle Recommendation Framework
In this chapter, we will discuss how the comprehensive lifestyle recommendations, are gener-
ated and distributed.
The proposed lifestyle recommendation framework is generally illustrated in Figure 5.1. It
contains three main components: 1) Lifestyle Data Aggregation and Preprocessing, 2) Temporal-
Weighted Regression (TWR), and 3) Model Postprocessing.
To evaluate this framework, we conduct a 3-month clinical trial to collect training data and
generate recommendations. Patients during the clinical trial upload various types of data si-
multaneously or at any times of a day; some are very noisy and abundant. As such, a data
aggregation and preprocessing module is designed to convert the raw lifestyle data into proper
training datasets for predictive tasks. Then, the proposed TWR (Temporal-Weighted Regres-
sion) should be able to identify the temporal patterns of blood glucose levels and convert them
into computer-generated recommendations.
In next sections, each component of this framework will be described in detail.
5.0.1 Data Aggregation
The GlucoGuide mobile client can collect more than fifty health features (such as medicine
records, meter readings, nutrients, physical activities, water intake, sleep pattern, weather, and
so on) for each patient daily. It is a very comprehensive feature vector which almost cover ev-
ery aspect of T2D diabetes management. However, it might not be feasible to include all these
features in the model, due to the data sparsity, missing values, noise in the data, and the fea-
ture irrelevance. Thus, finalized by our medical team, the most relevant sixteen features were
delicately selected to characterize the main characteristics of T2D patients’ daily activities, as
listed in Table 5.1.
All heath features except for nutrient intake (discussed in the previous section) were recorded
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Figure 5.1: T2D lifestyle recommendations framework
via different medical devices as described in Figure 5.2. For example, the glucometer (One-
TouchUltra2, see Figure 5.2a) can record the blood glucose level and automatically send the
readings to GlucoGuide clients via Bluetooth. The full Bluetooth-enabled medical device list
is shown in Figure 5.2.
Among all features listed in Table 5.1, the blood glucose level is treated as the dependent
variable or target variable and the rest fifteen features are used as independent variables or
features. Some previous works have shown correlations between blood glucose level and the
independent variables we used [50, 51]. However, the exact relation will be found in our
predictive models, to be discussed next.
5.0.2 Data Pre-processing
Not like the continuous CGM data, diabetes specialists (doctors) usually advise T2D patients
to check their blood glucose level (by using glucometers) at the following two critical times of
the day. The first one is the fasting blood glucose, usually taken early in the morning before
breakfast. This may reflect the overall status of the diabetic condition in the previous day. The
second is the blood glucose level taken two hours after a main meal. Such blood glucose levels
reflect more directly the effect of the meal two hours ago.
Our health team advise our patients in the clinical trial to check their fasting blood glucose
levels daily, and their after-meal blood glucose regularly (mainly the main meal of the a day).
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(a) OneTouchUltra2 glucometer with PolyMap
Bluetooth addon
(b) OmronHJ-720ITC pedometer with Blue-
tooth docking station
(c) AND UA0767BT blood pressure monitor
Figure 5.2: Medical devices list in clinical trial
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Table 5.1: Health features used in clinical trial
Relevant Feature Recording Method Unit
Blood Glucose Level Glucometer mmol/L
Last Blood Glucose Level Glucometer mmol/L
Pulse Blood Pressure Monitor beats/minute
Systolic Blood Pressure Monitor mmHg
Diastolic Blood Pressure Monitor mmHg
Step Count Pedometer Steps
Aerobic Step Count Pedometer Steps
Carbohydrates Intaken Food database gram
Fat Intaken Food database gram
Proteins Intaken Food database gram
Calories Intaken Food database kcal
Calories Consumption Estimated via step counts kcal
Meal Counts Counting times
Carbohydrates Ratio Food database percentage
Fat Ratio Food database percentage
Proteins Ratio Food database percentage
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The recorded blood glucose levels, along with other raw lifestyle data, must be pre-processed
and converted into a specific format so that predictive algorithm can apply. In addition to the
traditional de-normalization process, we design a practical data aggregation scheme.
Specifically, we have created two types of data instance for the predictive task:
• Fasting instance: When GlucoGuide Engine receives a fasting blood glucose recorded
by a patient, the blood glucose timestamp is first extracted. Then, lifestyle data recorded
within the window of the previous day are aggregated to generate an entry of the fasting
dataset.
• After-meal instance: When GlucoGuide Engine receives an after-meal blood glucose
recorded by a patient, the blood glucose timestamp is extracted. Then, lifestyle data
within the 4-hours window before that timestamp are aggregated to generate an entry of
After-meal dataset. The window is set to 4 hours to include more relevant data.
Data cleaning process is then performed to obtain qualified data instances. In particular, dupli-
cate data are removed since they presented a source of error. Missing values are replaced with
the rolling average value of each individual’s data. All numerical features (except for the target
label blood glucose) are scaled to be in the range of [0, 1].
Note that our clinical dataset is not publicly accessible since we must follow an approved
clinical ethics protocol. However, other researchers can contact us and sign a confidentiality
agreement (CA) to obtain a de-identified copy of the dataset.
To mine the lifestyle data after pre-processing, we have proposed a predictive algorithm
called TWR (Temporal-Weighted Regression). It can learn timely health patterns and generate
recommendations accordingly with minimal generalized errors. We will discuss this frame-
work in the subsequent subsections.
5.0.3 Temporal-Weighted Regression (TWR)
Challenges and Contributions
Designing and adopting an efficient, robust, and reliable model to mine real T2D patients’ data
stream is challenging. Firstly, T2D lifestyle data is costly since they are from a variety of sen-
sors, food database queries, real blood glucose samples from patients. The cost of lifestyle data
collection indicates that the scale of such dataset could not be large and we need to overcome
the overfitting issue (too many features vs. few data instances). Secondly, patients may forget
to upload the data, or make mistakes during the data recording and uploading. These issues
cause the data stream to be noisy and sparse. On the other hand, in order to keep patients
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motivated, we need to start sending recommendations shortly, within several days, instead of
weeks or months later. Lastly, as more data are accumulated over time and patients have been
making good lifestyle changes, our system must weigh the recent data more than those in the
distant past. Clearly, all of these domain-specific challenges require the model to be robust and
adaptive.
Since the dependent variable (blood glucose) and independent variables (shown in Ta-
ble 5.1) are all numeric, regression framework thus becomes the most suitable solution for
the blood glucose prediction task. Also, regression with regularization is well-known to pre-
vent model overfitting, and generate models for better interpretation (smaller or zero feature
coefficient).
Although regression with regularization has been researched for years [52], [53], [54], we
still make the following contributions in the TWR framework.
The first contribution is that in TWR we proposed a straightforward yet effective temporal
weighting mechanism, which is essentially a function of time to weigh data uploaded at differ-
ent times. The more recent data, the more weight they carry. Thus, TWR adapts quickly to the
change of new lifestyle data as patients are taking our recommendations. The second contribu-
tion is the implementation of an online parameter tuning strategy that automatically conducts
the model and feature selection. Last but not least, the deployment of TWR into T2D treatment
itself is novel and is shown to be effective in the clinical trial (see later). This research could
also inspire other researchers to design better predictive applications in other mobile health
domains.
At a high level, TWR has been deployed in the GlucoGuide Engine and triggered weekly
to generate lifestyle recommendations for each patient. In every recommendation cycle, it
generates a group of candidate models for each patient based on different parameter settings.
The model with the smallest error on patient blood glucose prediction was chosen. From the
best model, TWR greedily chooses the most relevant health feature(s) and converted it into
recommendations using predefined NLP (Natural Language Processing) templates and domain
knowledge. We will present technical details about TWR below.
TWR Cost Function
TWR is essentially a form of locally weighted regression, a memory-based framework that
performs regressions around a data instance of interest using only the training data that are
“local“ to that point [52]. It weights the training instances according to their distance to the
test instance and performs regression analysis on the weighted data. Training instances close
to the target instance receive higher weights while those far away receive low ones.
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Many distance-based weight functions, such as Euclidean distance, Gaussian kernel, and
so on, can be used. For our problem, we use the temporal-factor to measure such distance
for two main reasons. Firstly, as we have mentioned, the more recent data instances should
be considered more informative in the training process. Secondly, our clinical data tend to be
noisier at the early stage of the clinical trial since the subjects are most elderly, and some of
them have long learning curves about GlucoGuide system.
Suppose we have collected N training instances for a specific patient. Each instance has a
target blood glucose level as the dependent variable yi, data entry xi with p dimensions, and
coefficient vector θ. We assume that the relationship between the independent variables (health
features) and dependent variable (blood glucose) is linear. According to Zecchin et.al [20], the
performance of linear and complex nonlinear models (such as ANN) on CGM blood glucose
predictions are not significantly different. However, linear model has the advantage of simple
structure, fast learning rate, and high interpolation. Thus, we first explore the usage of the
linear model on blood glucose prediction.
We define the cost function for the blood glucose regression model as in Equation 5.1.
J(θ) =
N∑
i=1
wit(yi − θ0 − xiθT )2. (5.1)
Here we assign a dynamic weight wit following a temporal decay for each training instance
i. Two typical decay functions are adopted to characterize the temporal decay: linear decay
function and exponential decay function. More specially, given an instance i, its weight wit is
defined as:
wit =

1 − dl−diL Linear,
β(dl−di)∑l
j=0 β
(dl−d j) Exponential.
(5.2)
where dl is the date when recommendation is generated (triggered) and di is the date of instance
i. Also, L determines the linear decay rate and is assigned to be the length of our clinical trial
(90 days). β is the exponential decay rate and will be optimized for each recommendation cycle
of each patient using cross-validation.
The above decay mechanisms are both functions of time. However, which function has the
better explanation ability of temporal importance needs to be determined via empirical studies.
Their comparison and evaluation will be presented at the end of this section.
Also, regularization is employed to address the overfitting problem, possibly caused by the
lack of qualified training instances and sparsity (potential p > N problem). Furthermore, the
interpretation of the model is also important for practical applications. A simpler model is
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preferred by the doctors because it can illustrate more clear relationships between the depen-
dent variable and the independent variables. As such, we have adopted a flexible regularization
framework called Elastic net [53], which was a compromise between the Ridge-regression (L2
form) [55] and the Lasso-regression (L1 form) [56]. The main advantage of the elastic net is
that it simultaneously conducts automatic variable selection and continuous shrinkage without
losing group effects (variables with high correlations or even identical). For example, carbo-
hydrate intake and total calories are highly correlated. If we employed L1 penalty, only one
feature of the group might be chosen, and the grouped information will be lost thus potentially
affect prediction accuracy.
The original cost function J(θ) is thus extended to a penalized form J′(θ) as shown in
Equation 5.3, along with the regularization penalty parameter λ. Note that Pα is a convex
combination of L1 and L2 penalty, where α is the elastic net mixing parameter, with 0 ≤ α ≤ 1.
J′(θ) =
N∑
i=1
wit(yi − θ0 − xiθT )2 + λPα(θ). (5.3)
where the elastic penalty Pα(θ) is defined as:
Pα(θ) =
p∑
j=1
[
1
2
(1 − α)θ2j + α|θ j|]. (5.4)
Cost Function Optimization
The cost function of TWR (Equation 5.3) is optimized using the cyclical coordinate descent,
which is an efficient and very fast algorithm to estimate the generalized regression with the
convex penalties [54, 57]. Cyclical coordinate descent minimizes J′(θ) along one gradient
direction at a time. The convergence is reached when no improvement is observed after one
cycle of line search along all directions.
Here is the detailed optimization process used in TWR. First, all elements of θ are initialized
with zero value. Then, suppose we already have the estimates θ˜0 and θ˜` (all ` , j), and we
would like to partially optimize the cost function J′(θ) by updating θ j = θ˜ j along its gradient
direction
∂J′(θ)
∂θ j
|θ=θ˜ = −
N∑
i=1
witxi j(yi − θ˜0 − xi˜θT ) + λ(1 − α)θ j + λα. (5.5)
Note that the above derivation only applies to θ j > 0. There will be a very similar equation for
θ j < 0, which we do not present here.
Then, we can update θ˜ j as follows:
θ˜ j ←
S
(∑N
i=1 w
i
txi j(yi − y˜i j), λα
)
∑N
i=1 w
i
tx2i j + λ(1 − α)
. (5.6)
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Figure 5.3: Contour plots of Ridge (L2), Lasso (L1), and TWR
where
y˜i
j
= θ˜0 +
∑
all`, j
xi`θ˜`. (5.7)
S (δ, γ) is the soft-thresholding operator [58] and calculated as:
sign(δ)(|δ| − γ)+ =

δ − γ, if δ > 0 and γ < δ
δ + γ, if δ < 0 and γ < δ
0, if γ ≤ |δ|.
(5.8)
Such an update process will be repeated in all directions till convergence (the convergence
threshold is set to 10e-5).
This cost function has the following properties:
• Convex
As clearly shown in Figure 5.3, the cost function (Equation 5.3) is strict convex.
• Variable Selection
The soft-thresholding will give penalties to the coefficient updates and keep the coeffi-
cients of irrelevant variables to be zero. As such, the generalized errors could be reduced
especially when the training data are insufficient.
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• Group Effect
The group effect means the coefficients of a group of highly correlated variables tend to
be equal. It is proved by Hui Zou and Trevor Hastie [53] that α , 1 (strictly convex)
guarantees the grouping effect.
• Temporal Weight
The designed linear and exponential reweighing mechanisms (Equation 5.2) weigh more
on the lifestyle data records closing to recommendation triggered date. Thus, the gener-
ated models should reflect more on patients’ recent lifestyle activities.
• Computational Efficient
Each step costs O(n) operations to calculate the gradient. A complete cycle through all p
variables costs O(pn) operations. Coordinate descent usually converges within 100 cy-
cles. This fast algorithm is particularly important to generate real-time recommendations
to potential large-scale of patients.
Online Parameters Tuning
In practical usage, TWR tunes the proposed two (linear/exponential) weighting mechanisms
with different parameter combinations in order to obtain the best model for each recommenda-
tion cycle. It assigned the value of α from 0 to 1 with a 0.1 increment and β from 0.5 to 1 with a
0.05 increment to generate a group of parameter combinations. For each combination of α and
β, TWR chooses the optimized λ giving the minimum cross-validated error from its candidates
sequence. The best model (with optimized α, β, λ) then is chosen to output recommendations.
5.0.4 TWR Model Evaluation
The effectiveness of TWR framework is evaluated mainly via measuring the MAE (Mean Ab-
solute Error) of the blood glucose predictions; other metrics included value range and standard
derivation.
We first compare TWR with other state-of-art regression methods including Lasso, Ridge,
and Elastic net. They are evaluated using the same patient dataset obtained from our clinical
trial (details about this clinical trial will be discussed in the next section). All methods are
using the same optimization approach (cyclical coordinate descent). The cost functions of
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Table 5.2: Prediction performance comparison of different regression models
Regression Method MAE
Lasso (α = 1) 1.0154
Ridge (α = 0) 0.9894
Elastic Net 0.9594
TWR with exponential decay 0.9475
TWR with linear decay 0.9273
these methods are shown as follows:
Lasso:
1
2N
N∑
i=1
(yi − θ0 − xiθT )2 + λ
p∑
j=1
α|θ j|.
Ridge:
1
2N
N∑
i=1
(yi − θ0 − xiθT )2 + λ
p∑
j=1
1
2
(1 − α)θ2j .
Elastic Net:
1
2N
N∑
i=1
(yi − θ0 − xiθT )2 + λ
p∑
j=1
[
1
2
(1 − α)θ2j + α|θ j|].
TWR:
N∑
i=1
wit(yi − θ0 − xiθT )2 + λ
p∑
j=1
[
1
2
(1 − α)θ2j + α|θ j|].
The results of the comparison are shown in Table 5.2. We can see that by assigning the
linear temporal weights, TWR obtains the best accuracy (with least MAE around 0.927) in our
experiments. This result is promising if we consider the normal blood glucose range of 4 -
15 mmol/L in our clinical trial. Thus, our results clearly show that TWR outperforms other
modern regression approaches for this type of real-world lifestyle dataset. To zoom-in to the
detailed blood glucose prediction, we plot the MAE for each patient, shown in Figure 5.4. The
x axis represents the patient ID and the y axis represents the MAE. The average value and
standard deviations are also shown in Figure 5.4. The best model performance is observed for
the patient ID 2 with the MAE 0.67 mmol/L. Even with the worst performance, the MAE is 1.26
mmol/L for the patient ID 7, which is still acceptable, as blood glucose fluctuates throughout
the day, and glucometers can have errors just as large. These results are also consistent with
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Figure 5.4: MAE of blood glucose prediction for each patient using TWR with linear decay
the state-of-art prediction performance (0.9 mmol/L) ([20, 59, 16]) using ANN and expensive
CGM data. However, we can achieve similar prediction accuracy using merely lifestyle data
and finger-prick blood glucose samples.
Although the MAE is very promising, as discussed above, the R2 measurement (also called
the ratio of deviation explained by the model) during the entire clinical trial is not very high
(0.45 ± 0.19). However, predicting human health outcomes is highly challenging and compli-
cated, thus, the results are still satisfiable under the practical circumstance. As we will show
in the next section, even such a level of model fitness can still achieve a significant clinical
improvement on patients with diabetes.
In summary, the experimental results indicate that our TWR is a reliable and effective
framework for analyzing real lifestyle data of diabetic patients. This model, as a important
component of GlucoGuide Engine, is validated to effectively predict on patients’ blood glucose
levels obtained in the clinical trial (see later in Section 5.1).
5.0.5 Model Postprocessing
As we have discussed, for each recommendation cycle, TWR generates a group of candidate
models with different parameter settings and choose the best-tuned model with the least MAE
to predict the blood glucose levels. With the selected model, it then ranks the features(s)
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with the largest coefficient (note that all features are already scaled and calibrated) to generate
recommendations. Such feature(s) corresponds the maximum impact on the blood glucose
levels. Thus, recommendations for changing those feature values can be generated, combined
with T2D domain knowledge and patients’ historical data.
To illustrate, suppose the discovered linear model is generated as follows:
BloodGlucose =
1.12 ×Carb + −0.88 × Pro+
0.038 × Fat + 0.056 ×Cals+
0.64 × ProProportion+
0.47 × FatProportion+
0.827 ×CarbProportion+
− 0.146 × S tepCount+
0.196 × Aerobic
Clearly, the heath feature with the largest coefficient is the amount of carbohydrate intake.
That is, lowering carbohydrate intake should lower the blood glucose levels the most. Thus,
the best recommendation is to slowly reduce carbohydrate intake, for this patient. In addition,
GlucoGuide will also search our food database to recommend diet replacement based on diet
guideline and nutrient equivalence. Such recommendations, after being compared to the dia-
betes guidelines or verified by our healthcare team, are wrapped in a natural language template
and sent to patients’ GlucoGuide mobile clients. An example of such a recommendation is
shown as follows:
By examining your uploaded health data we have seen that your Carbohydrate and blood
glucose levels are highly related. Consider reducing the proportion of carbohydrates you eat
at dinner to better control your after dinner blood glucose. For example, try replacing some of
the pasta in your meal with an extra portion of lean meat or vegetables, both of which have a
lower Carbohydrate content and often help with satiety.
The complete recommendations list and their validation rules are detailed in Appendix A.
5.1 GlucoGuide Clinical Trial
Preparing and conducting a clinical trial on human subjects is very expensive and resource-
intensive. It is estimated that the averaged cost per enrolled subject is slightly more than
6,094 USD (ranged from 2,098 USD to 19,285 USD) [60]. In particular, our clinical trial
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costs around 4,000 CAD per subject including the cost of technology package (Software de-
velopment/maintenance, mobile devices with GlucoGuide installed, and medical devices such
as glucometers, etc.), laboratory blood tests, training sessions, cellular data communication,
subjects follow-ups and questionnaires, etc.
Given the constraint of our budgets, we could only conduct a relatively small clinical trial.
However, we set up restrict criteria to ensure the representativeness of our subjects group. The
inclusion criteria were: a recent diagnosis of T2D or prediabetes, age between 18 and 80 years,
with a survey that concludes a sedentary or low active lifestyle, which was confirmed using the
7-day Physical Activity Recall Questionnaire. In addition, subjects who had difficulties under-
standing English, were taking more than two diabetes medications, were suffering from severe
mental disease or malignant disease, or were abusing drugs were excluded from participation
in the study.
At the end of the enrollment, we sampled seventeen adults included seven men (41%) and
ten women (59%), with one person in an ethnic minority group (6%) and four individuals with
less than a college degree (24%). The average age of the subjects was 62 years (±8). At
baseline, men had a mean weight of 105.8 kg (±19.6) and a Body Mass Index 1 of 35.1 kg/m2
(±6.4). Women had a mean weight of 90.0 kg (±19.9), and a BMI of 34.3 kg/m2 (±6.3).
Ten subjects are selected to be in the Intervention Group (INT). They are given the
GlucoGuide package and taught how to use it in the training sessions. The Control Group
(CON) includes the rest seven subjects with allied health and physical conditions who do not
use GlucoGuide. They are instructed to use standard paper logbooks to keep track of their
blood glucose levels, diet, and other similar lifestyle data. Thus, subjects in both groups need
to record and keep track of their lifestyle data; the main difference is that the subjects in the
intervention group use GlucoGuide with data recording and receive, several times in a week,
personalized recommendation while subjects in the control group would not receive any such
recommendations. Primary evaluations include two standard clinical blood tests: Fasting blood
glucose (FBG) and laboratory-measured A1c (or HbA1c), conducted in the clinical labs (i.e.,
not at home), for all subjects, before and after the trial. To elaborate, fasting blood glucose is
a measure of the amount of glucose in the blood stream after an 8 hour fast, usually overnight.
A1c, on the other hand, is proportionally related to the amount of glucose in the blood stream
over a long period of time (not affected by day-to-day changes). Therefore, A1c provides an
indication of average blood glucose levels over a longer time, usually three months.
A clinical diagnosis of diabetes is made when fasting blood glucose > 7.0 mmol/L or A1c
> 6.5%, while fasting blood glucose between 6.0 mmol/L and 6.9 mmol/L or an A1c between
1BMI, a measure for human body shape based on an individual’s mass and height, T2D patients usually have
high BMI
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Figure 5.5: Comparison of A1c and fasting blood glucose reduction between two groups, before
and after the trial
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6.0% and 6.4% is considered prediabetes. A normal person’s fasting blood glucose should be
less than 6.0 mmol/L, and an A1c less than 6.0%. (Note that the values of fasting blood glucose
and A1c are not equivalent or equal, but this is beyond the scope of this thesis). By analyzing
the differences of A1c and fasting blood glucose between the two groups, before and after the
trial, we can clinically evaluate the effectiveness of GlucoGuide on patients in our clinical trial.
Clearly, for both A1c and fasting blood glucose values, smaller values are better, and reduc-
tions in these values usually represent an improvement in diabetic condition.
Differences in both A1c and fasting blood glucose reduction between the two groups have
been observed before and after the trial. As shown in Figure 5.5a, subjects in the intervention
group had an average of 0.36% A1c reduction compared to only 0.10% in the control group.
Such an A1c reduction for patients with diabetes is clinically significant when considering the
differences in A1c for normal, pre-diabetic, and early diabetic people are quite small. A larger
difference can be observed in the fasting blood glucose reduction before and after the trial. For
the intervention group, the fasting blood glucose reduction was 0.770 mmol/L, comparing to
only 0.086 mmol/L in the control group.
To test the statistical significance, we conducted unpaired T-test on both A1c and fasting
blood glucose reductions between the intervention and control groups. If we use p = 0.10
as the significance level, the differences between the two groups on the A1c reduction and the
fasting blood glucose reduction before and after the trial are significant (p = 0.08 and p = 0.06
respectively). However, our significance levels are just above the stringent level of p = 0.05
due to the small sample size. To further evaluate the efficiency of GlucoGuide, a larger clinical
trial will be conducted in our future work.
To conclude, patients who use GlucoGuide in our clinical trial reliably improve their dia-
betic condition after only three months. Roughly speaking, GlucoGuide amounted to turning
an early diabetic patient to be pre-diabetic, and pre-diabetic to non-diabetic, in three months.
5.1.1 Adherence to Recommendations
In the best scenario, patients using GlucoGuide should follow or adhere all recommendations
made by GlucoGuide. However, most patients in our clinical trial could not adhere 100% to the
recommendations made by GlucoGuide. As such, we have defined the Adherence to Recom-
mendations (ATR) ratio for the subjects using GlucoGuide, reflecting how well they adhere the
GlucoGuide recommendations throughout the trial. Then we can build an Adherence Model
to predict patients’ A1c and fasting blood glucose reduction if they had adhered 100% to the
GlucoGuide recommendations.
Here is how we define the ATR (Adherence To Recommendations) ratio. We first divide
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Figure 5.6: Estimated 1.23% A1c reduction if a patient has 100% ATR
all recommendations into 14 categories. For each category, we design rules to decide if the
recommendation is adhered or not. For example, one recommendation type is about reducing
the carbohydrate intake. If patients do reduce the carbohydrate in future days, we consider
that the patients have adhered to the recommendation. AR is then defined as the ratio on the
adhered recommendations over all recommendations sent to the patients. Clearly, the range of
ATR is from 0 to 100%, where 100% means that patients adhere completely to GlucoGuide’s
recommendations.
We build simple linear regression models to predict the A1c and fasting blood glucose
reductions using ATR as an independent variable. Both linear models have positive slopes,
indicating that the more the patients adhered to GlucoGuide recommendations, the more A1c
and fasting blood glucose reductions could be achieved. The graph for A1c is illustrated In
Figure 5.6. This Adherence Model predicts that if patients had adhered 100% to GlucoGuide
recommendations, the expected reduction on A1c would be 1.23%. Also, the expected re-
duction on fasting blood glucose would be 1.03 mmol/L, having patients adhered 100% to
GlucoGuide recommendations (graph not shown).
Considering the differences in A1c and fasting blood glucose for normal, pre-diabetic, and
early diabetic people are quite small, people with diabetes would achieve highly significant
improvement if they adhere better to GlucoGuide’s recommendations.
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5.2 Relationships to Previous Works
The use of mathematical models in clinical diabetes is well-known [61], [62]. However, most
of the previous research works focus on using predictive models to generate long-term health
outcomes such as diagnosis prediction, A1c, complications, etc., as discussed in our literature
review. On the contrary, GlucoGuide uses predictive models on short-term health outcomes:
lifestyle changes to better control blood glucose levels. Recommending lifestyle changes, as
in GlucoGuide, is a form of action mining. It is an important topic in predictive. It aims
to generate action plans to maximize the gain or provides personalized recommendations for
individuals. Ling et al. [63] first proposed a novel algorithm to suggest actions of changing
customers from an undesired status (such as disloyal) to a desired one (such as loyal). However,
they used the decision tree model as the target variable is discrete, while in our case, the target
variable (the blood glucose levels) is continuous. Thus, an improved regression is used in
GlucoGuide.
Qiang et al. [64], [65] extended and refined the decision-tree approach by considering it as
a constrained optimization. Their approach is again only applicable to the classification tasks,
while GlucoGuide is a regression problem. In addition, those previous works did not consider
the involving nature of lifestyle data instances in our work and did not include any temporal
information as we did in GlucoGuide.
5.3 Conclusion
The efficiency of self-management for Type-2 Diabetes (T2D) is well-known but remains
highly challenging to implement for both patients and doctors in the practice. Our clinical
trial shows that GlucoGuide does help T2D patients to alleviate their diabetes conditions based
on two standard clinical blood tests. Our adherence model also predicted that the more they
adhere to GlucoGuide recommendations, the better the glucose control they would achieve.
In fact, the main difference of diabetes practice between the CON group and INT group is
the usage of the entire GlucoGuide system. Thus, it is difficult to point out and compare the
clinical efficiency of each sub-system of GlucoGuide (components such as food classification,
user interface, Web portal, lifestyle recommendations, etc.) specifically. In the future, more
specific clinical trials are needed to distinguish the efficiency of each component of GlucoGu-
ide.
The core function of our lifestyle recommendation framework is the blood glucose pre-
diction. Due to the constrains of resources, the diabetic lifestyle data collected in the clinical
trial are limited. It means the TWR framework is probably not converged to his full prediction
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potentials. In addition, we also want to explore the prediction performance of other non-linear
and complex models such as ANN or RandomForest, which usually require a huge amount of
training data.
In the next chapter, we will discuss how the small clinical dataset can be expanded and
enhanced to large scientifically-controlled datasets for more comprehensive blood glucose pre-
diction tasks.
Chapter 6
Predicting Blood Glucose with Data
Expansion
6.1 Blood Glucose Prediction: State-of-the-Art
With nearly two decades’ research and development, it is possible now to predict near future
blood glucose levels (e.g., 30 or 60 minutes later) within reasonable prediction error ranges.
This could be very useful for hyperglycemia/hypoglycemia warnings. For example, if a patient
is informed with an extremely high after-meal blood glucose (such as 15 mmol/L), he/she
can proactively conduct suitable actions such as increasing moderate/vigorous exercise, and/or
adjusting insulin dosage, etc., to stabilize blood glucose beforehand.
The methods of blood glucose prediction reported in the literature can be mainly divided
into two groups. The first group uses mathematical models to simulate the physiological dy-
namics of the glucose-insulin regulatory system. However, due to the complexities of the
human body, it is not possible for a simple mathematical model, to precisely predict an indi-
vidual’s blood glucose levels. The second group includes machine learning and data-driven
models, which aim to predict blood glucose based on training datasets. The main advantage of
data-driven approaches is that they do not require much previous knowledge about the physi-
ology of diabetes. However, a large amount of qualified training data is required for machine
learning models to achieve satisfying generalization-errors levels.
Most previous machine learning-based researches focus on continuous blood glucose mon-
itoring (CGM) data. CGM is an advanced technology to measure glucose levels in a real-time
throughout the day and night. CGM sensors are inserted under the skin to measure glucose lev-
els in tissue fluid. They are connected to a transmitter sending the blood glucose information
via wireless networks. An example of CGM dataset is shown in Figure 6.1, which is a sample
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of CGM data of a 14 years old T1D patient, sampled every 5 minutes. From Figure 6.1, we can
observe a blood glucose peak from 9:50 AM to 11:15 AM after breakfast and be stabilized via
insulin injection or medication intake. AutoRegression (AR) [66, 67, 68, 69, 70, 71, 72, 73] is
Figure 6.1: CGM data of a 14-years old T1D patient, sampled every 5 minutes
the first proposed and also the most popular framework to predict time-series CGM readings.
A general linear AR model can be formulated as:
y(t) =
M∑
i=1
wi(t)y(t − i) + e(t). (6.1)
where y is the blood glucose at time t, M denotes the order of the AR model, e(t) is as white
noise with E[e(t)] = 0 and var[e(t)] = θ2, and wi is the weight/coefficient of previous blood glu-
cose readings. The future blood glucose prediction yˆ(t + PH) by using a weighted combination
of history signals before time t:
yˆ(t + PH) =
M∑
i=1
wi(t)y(t − i). (6.2)
where PH is the prediction horizon. The coefficient of AR model can be learned usually via
least squares-wised algorithms.
To illustrate AR’s performance, we used an univariate AR(12) time series model to fit a
demo dataset, i.e., the 14-years old T1D patient dataset (around 50,000 readings) by ordinary
least squares (OLS) method. The prediction performance is measured by prediction residual.
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The mean of prediction residual is 0.11 mmol/L. As we can see from Figure 6.1, the prediction
errors ranged from 5 to -5 mmol/L but most are less than 1 mmol/L, indicating AR model is
quite effective on this demo dataset.
AR framework has been improving and refining by researchers. Sparacino et al. [67, 68, 70]
archived sufficient prediction accuracy by using first-order polynomial AR(1) model, with
time-varying parameters (coefficients) learned via recursive least squares (RLS). They also
introduced a constant forgetting factor to reduce the weights of blood glucose readings. Eren-
Oruklu et al. [71] used AR(3) and auto-regressive with moving average (ARMA) models, with
time-varying parameters learned via RLS. Their forgetting factor can be modulated according
to the glucose trend. Gani et al. [72] developed an AR(30) model with time-invariant parame-
ters identified by regularized LS. Finan et al. [73] propose an AR model with extra exogenous
inputs given by ingested carbohydrates and insulin medications. Artificial Neural Networks
Figure 6.2: AR(12) prediction residual on a 14-years old T1D patient demo dataset prediction
(ANN), as a very powerful non-linear predictive framework, has been employing in CGM
blood glucose prediction recently [1, 20, 16, 18, 19, 59].
ANN is a modeling tool that consists of simple processing elements, called neurons, linked
to each other through weighted connections. The main goal of ANN training is to learn those
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weights in order to minimize the estimation errors. The main advantage of ANN is that it
can learn the relationship between input and output without strong assumptions on the target
system. Figure 6.3 shows the basic principle of ANN for CGM blood glucose prediction.
Pe´rez-Gandı´a et al. [1] first proposed the idea of CGM prediction using ANN in 2010. The
Figure 6.3: ANN architecture for t+PH blood glucose used previous 20 minutes blood glucose
readings, cited from the origin paper [1].
inputs of their designed ANN were the values provided by CGM devices during the previous 20
minutes readings, and the outputs were the prediction of blood glucose concentration at chosen
PHs (15, 30, and 45 minutes). Their performance was estimated via RMSE (root-mean-square
error), with results ranged from 10, 18 and 27 mg/dl (0.55, 1.0, 1.5 mmol/L equivalently) for
15, 30, and 45 minutes of PH respectively. They claimed that ANN model is more accurate
than linear AR models.
Pappada et al. [59] refined ANN-based CGM prediction by adding more inputs such as
insulin dosage, nutritional intake, lifestyle, and emotional facts, into ANN model. However,
the reported prediction error is relatively high (2.43 mmol/L) due to the imbalance (limited
number of hypoglycemic CGM readings) of their training data.
Zecchin et al. [20] proposed a hybrid model combining both an ANN and AR(1) model in
parallel to model the nonlinear and linear components of blood glucose. The main rationale is
that they believe the performance of the linear AR models decreases for after-meal blood glu-
cose trend (usually blood glucose peaks). Thus, they argue that the relationship between blood
glucose and meal information is nonlinear, which is related to the glucose rate of appearance
after a meal, modeled by previously published physiological models. As such, they modeled
the yˆ(t + PH|t), the glucose concentration at t + PH as the sum of two components,
yˆ(t + PH|t) = yˆl(t + PH|t) + eˆ(t + PH|t). (6.3)
where yˆl(t + PH|t) is the glucose prediction via AR model and eˆ(t + PH|t) is the estimation
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of the error introduced by the AR model, which is modeled via ANN model. Their evaluation
results on twenty simulated datasets and nine real datasets showed that the integration of meal
information dose improve the prediction accuracy but not significantly.
Later, Zecchin et al. [16] improved ANN-based blood glucose prediction via modifying the
architecture of their predictors mentioned in [20]. A modified ANN model called jump NN,
i.e., a feed-forward NN whose inputs are not only connected to its next hidden layer, but also to
the output layer. Their empirical studies showed that such new model resulted not statistically
different than the previous model proposed in [16]. However, they believe that the new jump
NN model has much simpler structure.
In addition to AR and ANN framework, the usages of other predictive models such as
SVM [74, 69], Regularized Learning [17], and Extreme Learning Machine [69] are also re-
ported in the literature.
In general, we think that the performance of CGM-based blood glucose prediction mainly
depends on the quality of training data (volume, sparsity, noise, etc.), the length of PH (typ-
ically 30 to 75 minutes), selected predictive framework, parameter tuning, etc. However,
the main disadvantage of CGM-based blood glucose prediction is its cost. For example, the
CGM datasets used in researches [1, 20, 16, 18, 19, 59, 69] were from a large-scale data-
acquisition clinical trial called DIAdvisor project, involving 90 patients across three sites in
Europe: France, Italy, and Czech Republic. The first round of this clinical trial has already
cost about 7.1 million Euro. Also, they claim that these datasets are the properties of clinical
researches and hospitals, meaning they are not publicly accessible. As such, their empirical
studies are difficult to be repeated and improved by other researchers.
Moreover, nearly 90% diabetic patients belong to T2D and usually do not need to use
CGM devices. The management tools they have nowadays are paper log-book, mobile apps,
glucometer, pedometers, insulin pens, etc., which are capable of generating a large scale of
non-clinical but diabetic lifestyle data.
6.2 Clinical Data Expansion and Enhancement
It is well known that the main efforts and overhead of conducting machine learning tasks come
from data collection and processing. Occasionally, researchers even have to develop a working
platform first for collecting training data (such as the GlucoGuide platform). As such, data
scarcity problem, also can be considered as “small data“ problem, is one of the main problems
of machine learning. The small size of data is often responsible for poor performances and
makes the extraction of the significant information for inferences is difficult.
Due to the constraints of resources, the diabetic lifestyle data collected in our clinical trial
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(detailed in the previous chapter) is not quite comprehensive regarding its dimensions and vol-
ume. Fortunately, GlucoGuide, as a commercialized platform now, is collecting lifestyle data
accumulatively from the users worldwide. Still, before we have collected sufficient training
data, we plan to design data expansion and enhancement mechanisms to create scientifically
controlled artificial datasets, as intermediate datasets between the small clinical trial dataset
and the large scale of real-world datasets for empirical studies.
In this simulation, we focus on the 2 hours after-meal blood glucose instance because it
involves more informative features (such as meals, exercise, etc.). To build the artificial after-
meal blood glucose dataset, we first design a new lifestyle feature vector on the basis of features
used in the clinical trial (Table 5.1, Chapter 5). We try to use parametric statistical inference
to find the properties of underlying distributions and potential dependencies of our clinical
dataset. We also apply diabetic domain knowledge to make certain assumptions about the
data and determine some important feature dependencies and parameters. Then, we generate
unlabeled lifestyle training datasets using the new feature vector. The last step is to send the
unlabeled datasets to a popular diabetes simulator called AIDA [75, 76, 77], as an oracle, to
generate after-meal blood glucose labels. Since AIDA can process insulin information, we
thus can add insulin features, which were not collected in the clinical trial. When the artificial
datasets are generated, we can conduct empirical studies to evaluate the quality of the artificial
datasets and the prediction performance.
6.3 Artificial Lifestyle Feature Vectors
We categorize the lifestyle health features into three predict levels based on their relevance to
blood glucose levels, as shown in Figure 6.4. We believe these predictors are able to cover
the main components of patients’ daily blood glucose management. Their dependencies and
relevance levels in this simulation have been determined via domain knowledge [2]. Note
that there are cross-level interactions, and not all predictors are necessarily significant to blood
glucose levels. We will explain these predictors and their interactions in the following sections.
6.3.1 L1 Predictions
L1 predictors are patients’ general profile information, including:
BMI. Relevant to patients’ height information.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 35.6 and σ = 4.3
inferred from the clinical data sample.
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Figure 6.4: The proposed three levels of lifestyle predictors used to predict after-meal blood glucose
levels
Sex. Gender information, correlated to daily calories target estimated by Harris-Benedict
equation [78], which is a method used to estimate patients’ Basal Metabolic Rate (BMR)
and daily calories requirements.
Follows discrete uniform distributionU with 45% to be female and to be 55% male.
Age. Correlated to daily calories target estimated by Harris-Benedict equation.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 61 and σ = 6
inferred from the clinical data sample.
A1c. Patients’ HbA1c information.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 0.066 and σ =
0.009 inferred from the clinical data sample.
Education. Education level.
Follows discrete uniform distribution U with 90% to be post-secondary or above and
10% to be below post-secondary.
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6.3.2 L2 Predictions
L2 predictors are mostly related to patients’ daily activities, containing more predictive infor-
mation about daily after-meal blood glucose levels, including:
Height. Height information, determined by BMI and weight.
StepLength. Patients’ stride length, estimated by Height.
TargetCalories, denoted as C. Energies needed to maintain daily activities, estimated
using Weight, Height, Age, and Sex and activities level. In this simulation, daily target
calories are distributed equally as 25±5% for breakfast, 25±5% for lunch, 8.75±2.5%
for the snack between breakfast and lunch, 8.75±2.5% for the snack between lunch and
dinner, 25±5% for dinner, and 8.75±2.5% snack after dinner. It is also designed that
patients will have 10% change to skip a meal.
Protein. Daily target protein intake, determined by target calories and calories break-
down ratio. Note that 1g protein generates 4 kcal calories.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 0.29 ∗ C/4 and
σ = 0.12∗C/4. The mean and sd value 0.29±0.12 represent the calories ratio contributed
by protein, inferred from the clinical data sample.
Fat. Daily target fat intake, determined by target calories and calories breakdown ratio.
Note that 1g fat generates 9 kcal calories.
Continuous normal distributionN(µ, σ2) with parameters µ = 0.21∗C/9 and σ = 0.18∗
C/9. The mean and sd value 0.21 ± 0.18 represent the calories ratio contributed by
protein, inferred from the clinical data sample.
Hourly StepCount. Hourly step count information, related to physical exercise activi-
ties. In the previous clinical trial, hourly step counts are collected use Bluetooth-enabled
pedometers.
Note that the hourly step counts could have correlations between each other. To test the
correlations among step count on different hours, we calculate and plot the covariance
matrix in Figure 6.5. As we can see from the Figure 6.5, most pairs have zero or small
covariance (less than 0.25). As such, to simplify, we assume the step count on each
hour is independent of other hours and we will fit each hour’s step count independently.
By analyzing the shape and properties (mean, standard deviation, skewness, kurtosis,
etc.) of step count samples collected in the clinical trial, we decide to hypothesize three
popular non-negative continuous distributions: Weibull Weillbull(λ, k), Gamma Γ(k, θ),
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Figure 6.5: The correlation matrix of hourly step counts recorded in the clinical trial
LogNormal lnN(µ, σ2) as candidates. Then, we use maximum likelihood estimation to
learn their parameters and Aikake’s Information Criterion to compare the goodness of fit-
ting. The best fitting distribution found for the step count sample is Gamma distribution.
Thus, we believe hourly step count sample
Follows continuous gamma distribution Γ(k, θ) with parameters shape k and scale θ in-
ferred from the clinical data sample (different hour has different parameter pair).
Moderate and Vigorous Exercise. In the previous clinical trial, the only exercise re-
lated data collected are step counts from pedometer. However, we also need to determine
the specific exercise types and durations. In fact, kinesiology researches show that there
is equivalence between a number of steps and physical activities [79]. By referring the
step conversion chart proposed by Purdue University [79], we make the following esti-
mations:
4500 hourly steps approximately equivalent to moderate intensity exercise with moder-
ate duration (30 minutes, 150 steps/min).
6500 hourly steps approximately equivalent to vigorous intensity exercise with moderate
duration (30 minutes, 216 steps/min).
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6.3.3 L3 Predictions
L3 predictors are the most relevant covariates, including:
Weight. Weight information, relevant to BMI.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 99 and σ = 5.0
inferred from the clinical data sample.
Carbohydrates. Daily target carbohydrates intake, determined by target calories and
calories breakdown ratio. Note that 1 g carbs generates 4 kcal calories.
Follows continuous normal distribution N(µ, σ2) with parameters µ = 0.50 ∗ C/4 and
σ = 0.13∗C/4. The mean and sd value 0.50±0.13 represent the calories ratio contributed
by carbs, inferred from the clinical data sample.
Renal Threshold of Glucose. The renal threshold of glucose (RTG) is the blood glucose
concentration at which glucose begins to be excreted by the kidneys into the urine, which
is an indicator of kidney function.
Follows discrete uniform distribution U with 10% to be Low, 80% to be Normal, and
10% to be High.
Renal function. Renal function is a measure of kidney’s working status.
Follows discrete uniform distributionU with 80% to be Normal, 20% to be Reduced.
Liver sensitivity. Liver sensitivity represents the insulin sensitivity of the liver.
Follows discrete uniform distribution U with 10% to be Normal, 80% to be Reduced,
and 10% to be Increased.
Periphery sensitivity. Periphery sensitivity represents the insulin sensitivity of the rest
of the body.
Follows discrete uniform distribution U with 10% to be Normal, 80% to be Reduced,
and 10% to be Increased.
Insulin. Patients’ daily insulin and dosage information.
Based on the properties of our clinical patients sample, such as aged, overweight, need
to reduce food intake, and A1c 6.6 ± 0.9%, etc. We use the insulin treatment suggested
by AIDA as follows:
– Humulin S, short-acting insulins. Humulin S is a short-acting human insulin, which
usually be taken 20 to 45 minutes before eating. Its peak activity occurs after
about 30 minutes and lasts for approximately 2 hours [80]. It is well-known that
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Table 6.1: Health features of the 2 hours after-meal blood glucose artificial dataset
Feature Name Description
MealTime Timestamp of this meal
MealType Type of this meal
MealCarb Carbs intake in this meal
MealCarb Ratio Percentage of calories from carbs
MealProtein Protein intake in this meal
MealProtein Ratio Percentage of calories from protein
MealFat Fat intake in this meal
MealFat Ratio Percentage of calories from fat
Calories Calories of this meal
SnackCarb Carb intake in the snack between meal and blood glucose testing
SnackProtein Protein intake in the snack between meal and blood glucose testing
SnackFat Fat intake in the snack between meal and blood glucose testing
Humulin S Dosage Active short-acting insulin dosage intake
Humulin I Dosage Active intermediate-acting insulin dosage intake
Step Count Step counts between meal and blood glucose testing
Aerobic Step Count Aerobic step counts between meal and blood glucose testing
Blood Glucose 2 hours after-meal blood glucose level
moderate or vigorous exercise could increase the efficiency of insulin. Thus, we
also apply Humulin S adjustment to be 30% reduction for moderate exercise and
50% reduction for vigorous exercise (both for 30 minutes moderate duration). This
adjustment mechanism is based on the Guidelines for Insulin Adjustment for Extra
Activity suggested by St Joseph’s Hospital, London, ON.
Suggested dosage: 4 units before breakfast and 2 units before supper.
– Humulin I Insulin, intermediate-acting insulins. Humulin I is an intermediate-
acting insulin. It is usually taken in the morning (before breakfast) and/or in the
evening (either before dinner or before bed). Its peak activity occurs after about 6
hours and lasts for approximately 10 hours [80].
Suggested dosage: 16 units before breakfast, 12 units before supper, and 14 units
before bed.
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6.3.4 Assemble Predictors and Construct Feature Vector
Based on the lifestyle predictors explained in the last section, we construct our feature vector
of the training dataset for blood glucose prediction, as shown in Table 6.1.
From the above discussion, we can see that the blood glucose prediction technologies allow
us to form a training set z = {(xµ, yµ), µ = 1, 2, . . . ,M}, |z| = M, where
xµ = ((t
µ
1 , x
µ
1), . . . , (t
µ
m, x
µ
m)) ∈ (R2+)m ,
yµ = (t
µ
b , y
µ) ∈ R2+ .
(6.4)
where M is the size of the training datasets and m is the size of the feature vector, tui is the
timestamp of feature xi in data entry µ, tb is the timestamp of blood glucose testing, and yµ is the
blood glucose value. Applying the predictive modeling framework, we try to use the lifestyle
training dataset z to find the relations between lifestyle data and blood glucose, parametrized
with θ
fz(x; θ) : xµ → yµ (6.5)
fz(x; θ) is constructed as the minimizer of certain regularized or non-regularized cost functions.
6.3.5 Feature Temporal Re-weighting
Since many predictors have time-variant effects (e.g., short-acting insulin reach its peak at 2
hours), we argue that the influence of each predictor on blood glucose level should be adjusted
according to their time difference, which is designed as a function of time difference. For each
data entry, we scale the decay factor of each feature xi among all timestamps. Note that this
temporal weight is feature-dependent, which is different from the instance temporal weight we
designed in the lifestyle recommendation model.
As such, we give any feature xi with a timestamp associated (e.g., meal time, snack time,
etc) an exponential temporal decay d(xi), to weigh its relevant to the after-meal blood glucose,
as shown in Equation 6.6.
d(xi) =
β(tb−ti)∑m
j=0 β
(tb−t j) xi. (6.6)
where xi is the ith feature, tb is the blood testing time and β = 0.8∆t is a selected exponential
decay function. As such, the Equation 6.5 is rewritten as
fz(x; θ) : d(xµ)→ yµ (6.7)
In the prediction performance evaluation section, we will show that the temporal feature
re-weighting do increase the prediction performance for most popular predictive models.
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6.3.6 Blood Glucose Labeling
The target variable is 2-hours after-meal blood glucose level yµ and labeled via sending lifestyle
data entry queries to AIDA simulator. AIDA is a popular diabetes simulator which enables
interactive simulation of plasma insulin and blood glucose profiles for demonstration, teaching,
self-learning, and research purposes. The AIDA interactive educational diabetes simulator (see
www.2aida.org) has been proved effective in numerous online-surveys, clinical trials, and
empirical studies[75, 76, 81, 82, 77].
AIDA requires all information from L3 predictors to predict 24 hours blood glucose tread,
as shown in Figure 6.6. In our case, we only take the discrete 2 hour after-meal blood glucose
sample as our labels.
Figure 6.6: 24 hours blood glucose trend, sampled every 15 minutes
6.4 Empirical Evaluation
We evaluate the quality of this data generation process from two aspects. The first one is to
compare the statistical properties the blood glucose levels (the target variable) between the
clinical samples and artificial samples. Our data generation process is validated if the blood
glucose levels in the artificial dataset are statistically similar to clinical trial sample. The second
aspect is the predictive capability of artificial datasets. To perform these two evaluation studies,
we generated a lifestyle dataset containing 100 patients over three months with 30,000 data
entries.
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6.4.1 Statistical Properties
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(a) Blood glucose levels in the clinical trial sample
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(b) Blood glucose levels in the artificial dataset
Figure 6.7: Distributions fitting (Weibull, Gamma, and LogNormal) on the blood glucose levels
of two datasets (the clinical trial sample and the artificial dataset (100 patients)). Two blood
glucose histograms have very similar shapes.
Exploratory blood glucose data analysis is our first step to validate the generated artificial
datasets. We use graphical techniques (Histograms/densities, Quantiles-Quantiles plot, Em-
pirical Cumulative Distribution Function (ECDF), and Probability-Probability plots) to visual-
ize the statistical properties of the empirical data and thus hypothesize the candidate families
of distributions which would fit well. As we can see in Figure 6.7, blood glucose levels in
both dataset are non-negative continuous and nearly normal distributed. Based on these prop-
erties, we choose the distribution candidates as Weillbull(λ, k), Gamma Γ(k, θ), LogNormal
lnN(µ, σ2).
The parameters in these candidates are estimated using maximum-likelihood methods. We
also use the most popular distribution K-S test to test if the data sample is from a reference
distribution statistically. The distribution fitting results show that all candidate distributions
have very similar AIC values, but LogNormal distribution has statistical significance in K-
S test 1. The fitted LogNormal distributions and other descriptive percentiles are shown in
Table 6.2. As we can see from Table 6.2, the blood glucose levels in the clinical trial sample and
1We reject the null hypothesis that the data sample is drawn from the LogNormal distribution if the p-value is
less than the significance level (0.05).
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Table 6.2: Descriptive percentiles and two fitted LogNormal distributions of blood glucose data
in clinical trial and artificial dataset.
Property Clinical Trial (mmol/L) Artificial (mmol/L)
Min 0.1 0.82
1st Quantile 6.0 6.6
Median 7.1 8.4
Mean 7.166 8.6
3rd Quantile 8.2 10.2
Max 14.5 27.6
Best-fit lnN(1.94, 0.282) (K-S test, p = 0.067) lnN(2.08, 0.382) (K-S test, p = 0.058)
the 100-patients’ artificial dataset share similar statistical properties and distributions, which
indicate that our data generation process is valid.
6.4.2 Prediction Capabilities Evaluation
Now the artificial training dataset is well-generated to have similar statistical properties with
an original clinical dataset. The next step is to evaluate the predictive ability of this artificial
dataset.
In our previous clinical trial, we applied generalized linear-model to predict blood glucose
and determine the feature relevance. In this study, since we now have much larger and more
informative datasets, we can investigate the prediction abilities of complex and non-linear mod-
els. As such, we choose four representative predictive models as: RandomForest (discussed in
Chapter 4), ElasticNet (GLMNET) (discussed in Chapter 5), ANN, and SVM.
The complete training dataset is randomly split into 5 subsets (10%, 20%, 40%, 60%,
and 100%). These percentages are equivalent to the number of patients since the total patient
number is 100. These subsets are used to evaluate the scalability of each model. For each
sub-dataset, we then split 70% of the data for model training, and 30% for model testing. Also,
we have prepared another validation dataset for parameters tuning. The prediction evaluation
metric is the standard MAE (Mean Absolute Error). After the standard parameter tuning (grid
searching) using the validation dataset, each model is well-calibrated to perform prediction
task on the training datasets. We plot their prediction performance in Figure 6.8.
As we can see in the Figure 6.8, the prediction errors of almost all models decrease with
the size of the training data. Simple-structured models, such as GLMNET and SVM, seem do
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Figure 6.8: Solid lines present the models enhanced with temporal weight (TW), dash lines represent
the regular predictive models. We can see that the integration of temporal weights improves the predic-
tion performance for all models. Also, the prediction performance increases with more training data for
most models.
not require too much training data to be converged. The start point is ten patients’ data over
three months, which have the similar size as our entire clinical trial dataset, are sufficient for
them to reach their prediction potentials. However, as for complex-structured models such as
RandomForest and ANN, they certainly require more data to reach their prediction potentials.
Thus, we do believe that our previous clinical dataset might not be sufficient enough to train
complex and non-linear models. Inspired by this fact, we argue that deep learning framework
such as Convolution Neural Network would achieve better prediction results on a large scale
of lifestyle datasets.
We also evaluate the feature temporal re-weighting mechanism. In Figure 6.8, solid lines
present the models enhanced with temporal weight (TW) described in Section 6.3.5 and dash
lines represent the regular predictive models. Obviously, we can see that the integration of
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temporal weights does improve the prediction performance of all models. We can see that
RandomForest-TW (best prediction error are 1.36571 mmol/L) and ANN-TW (1.349877 mmol/L)
outperform other candidates on this training dataset. These MAE values are larger than the one
(0.9273 mmol/L) we reported in the clinical trial studies. However, the clinical trial samples in
fact have much smaller value range as shown in Table 6.2.
This study also suggests a linear model, even with complex regularization such as ElasticNet,
might not be the best prediction model in terms of blood glucose prediction accuracy. How-
ever, compared to the complex models such as ANN, the comprehensibility of the linear model
is very high. This advantage is in fact important and practically valuable for clinical decision
supports.
The artificial blood glucose datasets can also be used for varieties of other machine learn-
ing empirical studies such as blood glucose warnings, missing value imputation, data sparsity
analysis, transfer learning, etc., as our on-going and future research works. Still, they are not
real-world datasets. In order to conduct more reliable empirical studies, we certainly need
large datasets with more feature dimensions and huge data volume. Fortunately, the commer-
cialization of GlucoGuide gives us such opportunities, and we can collect large lifestyle data
worldwide now. The spin-off of GlucoGuide and our future research objectives will be briefly
described in the next chapter.
Chapter 7
GlucoGuide Spin-off
GlucoGuide Corp., established since Feb 2015 (https://glucoguide.com), aims to use ma-
chine learning technologies to tackle the two main challenges of diabetes self-management,
i.e., complexities of data input and lacking of short-term and personalized recommendations, as
detailed in Chapter 3. In particular, we have been researching and developing computer vision-
based approaches to reduce the complexities of lifestyle data input and provide evidence-based
lifestyle recommendations for patients to stabilize their blood glucose effectively.
GlucoGuide has received several rewards and raised approximately 1 million CAD R&D
fundings mainly from NSERC I2I, MITACS, and Angel Investments (See Appendix B for de-
tails). At this point, the main functionalities of GlucoGuide have been developed, and it is at the
stage of promotion and increasing user base. We believe that our user base will explode soon
because many GlucoGuide users believe that it is the best diabetes self-management system
they have seen. We been collaborating with many health organizations such as the nonprofit
organizations like CDA, local Diabetes Education Centers (DECs), and for-profit organizations
like MedPoint).
7.1 Current Status
Stable versions of GlucoGuide mobile clients for both Android and iOS can be downloaded
from Google Play and App Store respectively and used to log lifestyle data and receive advice
and recommendations from data-analytics algorithms. With the current version of GlucoGuide,
users are able to:
• Log and track data, including diet, exercise, sleep, blood glucose, insulin, A1c, weight,
etc., as shown in Figure 7.1. Users can also use reminder functions to one-click log the
data.
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Figure 7.1: Users can use GlucoGuide mobile clients to conveniently log varieties of lifestyle
data and receive recommendations
• Receive evidence-based lifestyle recommendations, some examples are also shown in
Figure 7.1.
• Log the diet data by snapping a photo of the meal and auto-estimate the nutrition facts,
as shown in Figure 7.2;
• Score their meal, based on a novel scoring system, as shown in Figure 7.2. The meal
scoring is a novel feature of GlucoGuide system, as it works with the existing data min-
ing system to give individualized feedback based on personal profile (such as weight,
height, gender, etc.) Note that the meal scoring system is designed to align with the
CDA Guidelines [2] (http://guidelines.diabetes.ca/Browse/Chapter11), and
with consultation from diabetes specialists and experts.
• View all the lifestyle data entered in a secure online logbook (https://myaccount.
glucoguide.com). The data are visualized with charts and trends as shown in Fig-
ure 7.3, and users can also print their logbook and bring them to their health providers;
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Figure 7.2: Log the diet data by snapping a photo of the meal and auto-estimate the nutrition
facts. A overall meal score is also generated to evaluate the whole meal.
7.2 Future Research Objectives
The current GlucoGuide system has already provided a comprehensive platform covering nearly
every aspect of diabetes self-management. For example, GlucoGuide is able to record detailed
information about each meal including the meal photos, specific food items in the meal, serving
and portion size, meal score, etc. As such, our future lifestyle feature vector can be expanded
to hundreds of thousands of dimensions. It is possible that in the future we can discover more
relationships between food items and blood glucose levels and provide more personalized and
detailed recommendations. Such as “Reducing 20% of the portion size of your home-made
sandwich to avoid high 2-hour blood glucose level“ or “30 minutes Yoga after dinner would be
the most effective way for you to control your fasting blood glucose“.
In fact, for a large feature vector, a huge amount of qualified training data are required to
fully describe the varieties of each feature and their relationships. Complex machine learning
frameworks are also needed to discover knowledge hidden in the big lifestyle data. Collect
such big lifestyle data and mine them with varieties of machine learning frameworks will be
our main future research objective.
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Figure 7.3: Users can review and print all their data using GlucoGuide online logbook.
Chapter 8
Conclusions
The efficiency of self-management for Type-2 Diabetes (T2D) is well-known but remains
highly challenging to implement for both patients and doctors in the practice. Based on the
challenges we discovered in the current diabetes management systems, we have proposed three
research questions and evaluated a novel system called GlucoGuide to answer them. We sum-
marize the answers to these questions as follows:
• Can we use classification models to generate real-time food guideline to help pa-
tients proactively manage their diet?
Answer: Evaluation results of our food classification tool show that it can achieve around
95% classification accuracy using RandomForest model on the proposed feature vector
combining textual and nutrient features. Thus, we can conclude that patients could re-
ceive empirically reliable real-time food recommendations using our tool. Note that our
food classes are subjective and labeled by health experts, which means they are not per-
sonalized and be changed over time.
• Can we predict T2D patients’ blood glucose level merely using lifestyle data and
discrete fingerstick-based blood glucose samples?
Answer: Evaluation results show that the MAEs of the proposed blood glucose predic-
tion framework are similar to the state-of-the-art results on both the real dataset and the
artificial datasets, using merely the lifestyle data and discrete blood glucose samples. In
fact, to the best of our knowledge, most related blood glucose prediction works are fo-
cused on CGM datasets mainly for T1D patients. We could not find the benchmarks of
blood glucose prediction for T2D’s lifestyle data but we believe there will be more simi-
lar research works in machine learning and computational diabetes management areas in
the future.
Also, we find that the prediction performance improved with temporal re-weighting
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mechanisms. We believe that the performance can be further improved by using deep
learning framework on a large scale of lifestyle data.
• Can we provide clinically effective lifestyle recommendations based on the outcomes
of blood glucose prediction?
Answer: Our clinical trial results suggest that GlucoGuide system could help T2D pa-
tients to alleviate their diabetes conditions based on two standard clinical blood tests. Our
adherence model also predicted that the more they adhere to GlucoGuide recommenda-
tions, the better the glucose control they would achieve. However, the main difference
of diabetes practice between the control group and intervention group is the usage of the
entire GlucoGuide system. Thus, it is difficult to point out and compare the clinical ef-
fectiveness of each component of GlucoGuide. In the future, more specific clinical trials
are needed to distinguish the effectiveness of each component.
Our work can be regarded as a proof of concept in integrating machine learning, mobile com-
puting, and medical knowledge into a mobile intelligent system that can benefit people with
chronic diseases, such as diabetes. We hope that our work could inspire future interdisciplinary
researchers to apply machine learning and mobile computing into the treatment and manage-
ment of other diseases.
GlucoGuide now is a university spin-off, allowing us to collect a large scale of practical
diabetic lifestyle data in terms of dimensions and volume. We can then design and implement
more advanced models to analyze the data and generate more personalized and effective rec-
ommendations. We hope our work would have potential impact on the entire diabetes treatment
and management area.
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Table A.1: Recommendation List
Type Condition Recommendation Templates
Carbohydrates Exceeds carbs tar-
get and has the
largest coefficient
• By examining your uploaded health data we have
seen that your carbohydrate and blood glucose lev-
els are related. Consider reducing the proportion
of carbohydrates you eat at dinner to better control
your after dinner blood glucose. For example, try
replacing some of the bread, rice or pasta in a meal
with an extra portion of meat or vegetables, both of
which have a lower carbohydrate content and often
help with satiety.
• Blood glucose was a little high after yesterday’s
meal. Try this trick: Heighten the flavour of your
foods with herbs, spices, vinegars, and mustards.
They’re all low calorie or calorie free and thus
don’t raise blood glucose levels.
• Based on your uploaded data, GlucoGuide has
found that carbohydrates are very linked to high
after-meal blood sugar. Consider reducing the to-
tal carbohydrates of the dinner meal by replacing
some of the grains in your meal (ex. rice, pasta,
bread) with vegetables or protein.
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Protein Exceeds protein
target and has the
largest coefficient
• Based on your uploaded data, GlucoGuide has
found that your protein intake is linked to your
blood glucose levels. To improve your blood glu-
cose levels try eating a smaller portion of protein
at meals. Ideally, we should all be eating between
0.8 - 1.8 grams of protein per kilogram of body
weight, and protein should make up 20% of our
total calories that we eat each day.
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Fat Exceeds fat target
and has the largest
coefficient
• Blood glucose was a little high yesterday. Think
about what you ate: was there a way you could
have made it a little healthier? Perhaps scaling
back the portion size, decreasing the amount of sat-
urated fat you have at dinner could make the differ-
ence. We’ve send a trend between your blood glu-
cose and the amount of fat you eat, so that would
be a good place to start!
• By examining your uploaded data, we have seen a
trend between the amount of fat you have at dinner
and your blood glucose levels. Try reducing the
portion size of the foods that have a high fat con-
tent, and increasing your intake of carbohydrates
and protein. For example, in your evening meal,
have a salad with garbanzo beans or black beans
added in to get extra protein, or try having a 1/2
cup of low-fat or non-fat yogurt with berries for
dessert.
• To improve your blood glucose levels try eating
foods with less saturated fat at meals. Ideally fat
should make up 30% of our total calories that we
eat each day. Lighten up on fats. For example,
decrease the amount of butter, oil, salad dressing,
cream cheese, sour cream and other fats you use.
They’re loaded with calories and some have un-
healthy saturated fat.
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Carb Ratio Carb ratio exceeds
target ratio and has
the largest coeffi-
cient
• Great healthy eating choices - by incorporating
whole grains and protein-rich Greek yogurt you
are fueling your body with the nutrients you need.
Keep seeking out ways to add those vegetables for
extra punch.
Protein Ratio Exceeds protein
ratio target and
has the largest
coefficient
• Based on your uploaded data, GlucoGuide has
found that your protein intake is linked to your
blood glucose levels. To improve your blood glu-
cose levels try eating a smaller portion of protein
at meals. Ideally, we should all be eating between
0.8 - 1.8 grams of protein per kilogram of body
weight, and protein should make up 20% of our
total calories that we eat each day.
Fat Ratio Exceeds fat ratio
target and has the
largest coefficient
• Great work incorporating an extra serving of veg-
gies to your meals. Looking to lighten up on satu-
rated fats. Look at the nutrition facts of butter, oil,
salad dressing, cream cheese or sour cream. Some
varieties are loaded with calories and too much un-
healthy saturated fat. Consider reducing your por-
tions or replacing them with lower-fat varieties.
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Step Counts Detected inactive
and has the largest
coefficient
• Your blood glucose levels have been a little high
before dinner the last two days. Consider adding
a short walk before dinner or between dinner and
your blood glucose measurement two hours after
dinner.
Aerobic Detected inactive
and has the largest
coefficient
• Your blood glucose levels have been a little high
before dinner the last two days. Consider adding
a moderate exercises before dinner or between
dinner and your blood glucose measurement two
hours after dinner.
• Physical activity is anything that increases your
heart rate. It is beneficial as it improves blood flow
to organs and helps body in the production of in-
sulin. Try reaching your training heart rate today
to improve your cardiovascular health!
Blood Glucose
Reminder
Missing blood glu-
cose testing for ad-
jacent three days
• Please remember to upload your evening blood
glucose: before and two hours after dinner.
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Data Record Re-
minder
Missing data up-
loading for adja-
cent three days
• Please remember to record and upload your
evening data: blood glucose before and two hours
after dinner, what you ate, your blood pressure and
step count.
• We’ve missed you the past couple days. Please
upload your dinner, blood glucose, blood pressure
and step count today. Way to meet your step count
goals the last few days!
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Blood Glucose
Target
Reach blood glu-
cose targets • Yesterday’s blood glucose levels look great. Way
to go! Healthy choices, incorporating lots of veg-
gies and fruits means that your body will get the
nutrients it needs.
• Awesome - blood glucose levels are looking really
good.
• Please upload what you’ve been eating for dinner.
Blood glucose is looking great lately, and we want
to see how you’ve achieved such success!
• You are doing well - blood glucose and blood pres-
sure are looking good today. Based on your up-
loaded data, GlucoGuide has found that carbo-
hydrates are very linked to high after-meal blood
sugar. Continue to replace some of the grains in
your meal (ex. rice, pasta, bread) with vegetables
or protein.
• Your blood glucose levels have been a little more
elevated than normal the last few days. Is there
something you’re doing differently?
• Your blood glucose was very high this morning af-
ter your meal. This may happen once in a while,
but it is better to keep levels steady. Food that has
fibre, protein, and healthy fats helps us do that. For
example, eating a meal with veggies and hummus
instead of chips and dip will keep your blood glu-
cose levels lower.
• Your blood glucose was quite low - if you aren’t
planning on having dinner, have a small snack,
with about 15 g of carbohydrates, such as an ap-
ple, an orange or a pear.
94 Chapter A. T2D Lifestyle Recommendations List
Blood Glucose
Warning
Abnormal blood
glucose levels
detected
• It looks like your blood glucose was very variable
today. To even out blood glucose swings, try to eat
smaller meals every 2-4 hours that include some
protein, fat, carbohydrates and fibre.
• It looks like your blood glucose was very variable
today. To even out blood glucose swings, try to eat
smaller meals every 2-4 hours that include some
protein, fat, carbohydrates and fibre.
• Your fasted blood glucose was quite low tonight -
we would like to monitor this. Please take your
blood glucose two hours after your meal.
• Your after dinner glucose level was very low
tonight. We’d like to monitor this. Please have
something to eat with at least 15 grams of carbo-
hydrates and repeat the measure in two hours.
• You are making great healthy choices! Remem-
ber to reward yourself - decide what kind of re-
ward would work best for you: maybe it’s praise
from your doctor, a new pair of running shoes, or
some time for reading a good book. Use the reward
you choose to treat yourself when you’ve reached
a goal.
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Step Count Target Reach step count
target • Great work uploading your data. Your daily step
counts are looking good: small steps towards
change, added together can yield big results for
your health and wellness.
• Blood pressure is looking good! Keep it up with
that step count, yesterday - 8000+! Fantastic.
• Small changes today will yield great results when
added together. Your step count is great, the next
step is adding those veggies and healthy snacks!
• Go for that step goal! Plan ahead: set aside time
in your day for activity, and you’re more likely to
follow through with it.
• 10,000+ steps yesterday! Awesome!
• Blood glucose levels and step count are looking
great. Keep it up - your healthy lifestyle can help
reduce your risk of disease!
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Encouragement No data driven rec-
ommendation gen-
erated and/or over-
all well performed
• Make small goals and then plan to celebrate when
you accomplish them! Reward is an important part
of goal setting. Ideas include: a relaxing walk, a
movie, a good book, or a chat with an old friend.
• Good work uploading your data. By uploading ac-
curate and complete information about your din-
ners we will be able to see what affects your blood
glucose most.
• Fantastic job uploading your data. Through
healthy eating and physical activity you are di-
rectly and positively affecting your health. Re-
member - slow and steady wins the race!
• BP looked good yesterday! You can now move to
just monitoring dinner. Keep on uploading your
dinner data accurately and completely, so that we
can find what is affecting your blood glucose most.
Appendix B
Rewards and Fundings
• The 1st prize for the best Clinical Research Presentation at the 2nd Annual Diabetes
Research Day by the Schulich School of Medicine & Dentistry in Nov 2011.
• 79,000 CAD R&D funding from 2014 NSERC Idea to Innovation Grants.
• Angel Investments from Jordann Capital Management Inc since 2014.
• 125,000 CAD R&D funding from 2016 NSERC Idea to Innovation Grants.
• 146,000 CAD R&D funding from 2016 MITACS Accelerate.
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